US20070181503A1 - Affinity particle and affinity separation method - Google Patents
Affinity particle and affinity separation method Download PDFInfo
- Publication number
- US20070181503A1 US20070181503A1 US11/580,000 US58000005A US2007181503A1 US 20070181503 A1 US20070181503 A1 US 20070181503A1 US 58000005 A US58000005 A US 58000005A US 2007181503 A1 US2007181503 A1 US 2007181503A1
- Authority
- US
- United States
- Prior art keywords
- particles
- affinity
- group
- groups
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002245 particle Substances 0.000 title claims abstract description 285
- 238000000926 separation method Methods 0.000 title claims abstract description 33
- 239000003446 ligand Substances 0.000 claims abstract description 105
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 claims abstract description 76
- 239000013076 target substance Substances 0.000 claims abstract description 64
- 239000010954 inorganic particle Substances 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims description 83
- 150000001875 compounds Chemical class 0.000 claims description 48
- 230000000274 adsorptive effect Effects 0.000 claims description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 45
- 230000008569 process Effects 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000377 silicon dioxide Substances 0.000 claims description 16
- 239000010445 mica Substances 0.000 claims description 15
- 229910052618 mica group Inorganic materials 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- -1 sericite Chemical compound 0.000 claims description 13
- 239000000454 talc Substances 0.000 claims description 11
- 229910052623 talc Inorganic materials 0.000 claims description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 10
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 108090001008 Avidin Proteins 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 239000000427 antigen Substances 0.000 claims description 7
- 108091007433 antigens Proteins 0.000 claims description 7
- 102000036639 antigens Human genes 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 230000005484 gravity Effects 0.000 claims description 7
- 229910021645 metal ion Inorganic materials 0.000 claims description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 6
- 108091023037 Aptamer Proteins 0.000 claims description 6
- 108020004414 DNA Proteins 0.000 claims description 6
- 101710120037 Toxin CcdB Proteins 0.000 claims description 6
- 108010052006 Mitogen Receptors Proteins 0.000 claims 4
- 102000018656 Mitogen Receptors Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 239000000843 powder Substances 0.000 abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 98
- 238000006243 chemical reaction Methods 0.000 description 57
- 125000003277 amino group Chemical group 0.000 description 52
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- 238000005119 centrifugation Methods 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 31
- 238000000746 purification Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 102000001554 Hemoglobins Human genes 0.000 description 22
- 108010054147 Hemoglobins Proteins 0.000 description 22
- 239000000126 substance Substances 0.000 description 22
- 239000012153 distilled water Substances 0.000 description 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 16
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000003607 modifier Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 11
- 239000006185 dispersion Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 229950004354 phosphorylcholine Drugs 0.000 description 11
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000000178 monomer Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 125000000524 functional group Chemical group 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000001179 sorption measurement Methods 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- JGENYNHRIOHZOP-UHFFFAOYSA-N CCOP(=O)([O-])OCC[N+](C)(C)C Chemical compound CCOP(=O)([O-])OCC[N+](C)(C)C JGENYNHRIOHZOP-UHFFFAOYSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 150000001299 aldehydes Chemical class 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- 241000283707 Capra Species 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 5
- 125000003172 aldehyde group Chemical group 0.000 description 5
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 5
- 238000007248 oxidative elimination reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000009210 therapy by ultrasound Methods 0.000 description 5
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000002262 Schiff base Substances 0.000 description 4
- 150000004753 Schiff bases Chemical class 0.000 description 4
- 239000006087 Silane Coupling Agent Substances 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 229940073579 ethanolamine hydrochloride Drugs 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000000087 stabilizing effect Effects 0.000 description 4
- 239000012134 supernatant fraction Substances 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- SRZQXACEDDIGEB-UHFFFAOYSA-N C[N+](C)(C)CCOP(=O)([O-])OCC(=O)O Chemical compound C[N+](C)(C)CCOP(=O)([O-])OCC(=O)O SRZQXACEDDIGEB-UHFFFAOYSA-N 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000001114 immunoprecipitation Methods 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000006268 reductive amination reaction Methods 0.000 description 3
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000004482 13C cross polarization magic angle spinning Methods 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- XLBDYAFYBRSDMR-UHFFFAOYSA-N 4-oxo-4-(3-triethoxysilylpropoxy)butanoic acid Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)CCC(O)=O XLBDYAFYBRSDMR-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 208000002109 Argyria Diseases 0.000 description 2
- SUHOQUVVVLNYQR-UHFFFAOYSA-N C[N+](C)(C)CCOP(=O)([O-])OCC(O)CO Chemical compound C[N+](C)(C)CCOP(=O)([O-])OCC(O)CO SUHOQUVVVLNYQR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000005046 Chlorosilane Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000010425 asbestos Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 229910052570 clay Inorganic materials 0.000 description 2
- 229920001688 coating polymer Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005384 cross polarization magic-angle spinning Methods 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011981 development test Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- AFLBAXPZSPPPIW-UHFFFAOYSA-N disodium;dioxidoboranylformonitrile Chemical compound [Na+].[Na+].[O-]B([O-])C#N AFLBAXPZSPPPIW-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 108010011903 peptide receptors Proteins 0.000 description 2
- 102000014187 peptide receptors Human genes 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 229910052895 riebeckite Inorganic materials 0.000 description 2
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000012808 vapor phase Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 150000000180 1,2-diols Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- QLHBLWZNBQPDAD-UHFFFAOYSA-N CCC(CN=C)O Chemical compound CCC(CN=C)O QLHBLWZNBQPDAD-UHFFFAOYSA-N 0.000 description 1
- SOHMQSOLAJWPID-UHFFFAOYSA-N CCC(O)CO.C[N+](C)(C)CCOP(=O)([O-])O.C[N+](C)(C)CCOP(=O)([O-])O.O=I(=O)(=O)O[Na].[H]C(=O)CC Chemical compound CCC(O)CO.C[N+](C)(C)CCOP(=O)([O-])O.C[N+](C)(C)CCOP(=O)([O-])O.O=I(=O)(=O)O[Na].[H]C(=O)CC SOHMQSOLAJWPID-UHFFFAOYSA-N 0.000 description 1
- OAGFXZZLQPHQQG-UHFFFAOYSA-N CCCCP([NH-])(O)=O Chemical compound CCCCP([NH-])(O)=O OAGFXZZLQPHQQG-UHFFFAOYSA-N 0.000 description 1
- CAQSCWUBFRYUOQ-UHFFFAOYSA-N CCCNCCC[Si]12O[Si](C)(C)[Si](C)(C)(C)(O1)[Si](C)(C)O2.CO[Si](CCCN)(OC)OC.C[N+](C)(C)CCOP(=O)([O-])O.C[N+](C)(C)CCOP(=O)([O-])O.C[Si](C)(O)[Si](C)(C)(C)(O)[Si](C)(C)O.C[Si]1(C)O[Si]2(CCCN)O[Si](C)(C)[Si]1(C)(C)(C)O2.C[Si]1(C)O[Si]2(CCCN)O[Si](C)(C)[Si]1(C)(C)(C)O2.[H]C(=O)CC Chemical compound CCCNCCC[Si]12O[Si](C)(C)[Si](C)(C)(C)(O1)[Si](C)(C)O2.CO[Si](CCCN)(OC)OC.C[N+](C)(C)CCOP(=O)([O-])O.C[N+](C)(C)CCOP(=O)([O-])O.C[Si](C)(O)[Si](C)(C)(C)(O)[Si](C)(C)O.C[Si]1(C)O[Si]2(CCCN)O[Si](C)(C)[Si]1(C)(C)(C)O2.C[Si]1(C)O[Si]2(CCCN)O[Si](C)(C)[Si]1(C)(C)(C)O2.[H]C(=O)CC CAQSCWUBFRYUOQ-UHFFFAOYSA-N 0.000 description 1
- WRHZBWXFBDYNHY-UHFFFAOYSA-N CO[Si](CCCNC(=O)COP(=O)([O-])OCC[N+](C)(C)C)(OC)OC Chemical compound CO[Si](CCCNC(=O)COP(=O)([O-])OCC[N+](C)(C)C)(OC)OC WRHZBWXFBDYNHY-UHFFFAOYSA-N 0.000 description 1
- JLFHOMSHCMVSCT-UHFFFAOYSA-N CO[Si](CCCNCCOP(=O)([O-])OCC[N+](C)(C)C)(OC)OC Chemical compound CO[Si](CCCNCCOP(=O)([O-])OCC[N+](C)(C)C)(OC)OC JLFHOMSHCMVSCT-UHFFFAOYSA-N 0.000 description 1
- GZSQCVJIBRDEPZ-UHFFFAOYSA-N CO[Si](CNC(=O)COP(=O)([O-])OCC[N+](C)(C)C)(OC)OC.CO[Si](CNCCOP(=O)([O-])OCC[N+](C)(C)C)(OC)OC Chemical compound CO[Si](CNC(=O)COP(=O)([O-])OCC[N+](C)(C)C)(OC)OC.CO[Si](CNCCOP(=O)([O-])OCC[N+](C)(C)C)(OC)OC GZSQCVJIBRDEPZ-UHFFFAOYSA-N 0.000 description 1
- NEISTHDBTKGRAE-UHFFFAOYSA-N C[N+](C)(C)CCOP(=O)([O-])OCC(O)O.[H]C(=O)COP(=O)([O-])OCC[N+](C)(C)C Chemical compound C[N+](C)(C)CCOP(=O)([O-])OCC(O)O.[H]C(=O)COP(=O)([O-])OCC[N+](C)(C)C NEISTHDBTKGRAE-UHFFFAOYSA-N 0.000 description 1
- ZUVSWCRSINNUID-UHFFFAOYSA-N C[N+](C)(C)CCOP(=O)([O-])OCN Chemical compound C[N+](C)(C)CCOP(=O)([O-])OCN ZUVSWCRSINNUID-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical group CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- YRUBNVYJEACDOR-UHFFFAOYSA-N [H]C(=O)COP(=O)([O-])OCC[N+](C)(C)C Chemical compound [H]C(=O)COP(=O)([O-])OCC[N+](C)(C)C YRUBNVYJEACDOR-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- WMWLMWRWZQELOS-UHFFFAOYSA-N bismuth(III) oxide Inorganic materials O=[Bi]O[Bi]=O WMWLMWRWZQELOS-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960004788 choline alfoscerate Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229910052629 lepidolite Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 239000011146 organic particle Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- OQWJABBWRMHXKG-UHFFFAOYSA-N tetradecanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCCCC(O)=O OQWJABBWRMHXKG-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- CMPGARWFYBADJI-UHFFFAOYSA-L tungstic acid Chemical compound O[W](O)(=O)=O CMPGARWFYBADJI-UHFFFAOYSA-L 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3204—Inorganic carriers, supports or substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
- B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
- B01J20/3257—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one of the heteroatoms nitrogen, oxygen or sulfur together with at least one silicon atom, these atoms not being part of the carrier as such
- B01J20/3259—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one of the heteroatoms nitrogen, oxygen or sulfur together with at least one silicon atom, these atoms not being part of the carrier as such comprising at least two different types of heteroatoms selected from nitrogen, oxygen or sulfur with at least one silicon atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3285—Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/58—Use in a single column
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Definitions
- the present invention relates to affinity particles and an affinity separation method. More specifically, it relates to affinity particles utilizing inorganic particles and an affinity separation method that allows easy and highly precise separation of the target substance.
- the present invention is very useful in various separation, purification, and testing methods including latex agglutination methods and immunoprecipitation methods that allow easy and highly sensitive detection of the target substance.
- Patent Document 1 affinity particles and affinity columns supporting ligands are used for separation and purification of the target substances.
- Patent Document 2 affinity particles and affinity columns supporting ligands are used for separation and purification of the target substances.
- inorganic particles adsorb more substances than organic particles do, therefore those skilled in the art didn't think of using inorganic particles for affinity particles.
- Patent Document 1 Japanese Patent Publication H8-26076
- Patent Document 2 Japanese Patent Laid-Open 2002-511141 bulletin
- Non-patent Document 1 Bioconjugate Chem.; 2002; 13(2); 163-166
- the object of the present invention is to provide a technological affinity separation method that uses affinity particles utilizing inexpensive inorganic particles and is capable of separating the target substance easily and with high accuracy.
- the present invention is very useful in various separation, purification, and testing methods including latex agglutination methods and immunoprecipitation methods that allow easy and highly sensitive detection of the target substance.
- the present invention provides affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles.
- the present invention provides affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having reactive groups or adsorptive groups, which are capable of bonding with ligands having specific affinity with a certain target substance, covalently bonded or adsorbed onto the surface of inorganic particles.
- the present invention provides affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having ligands having specific affinity with a certain target substance covalently bonded or adsorbed onto the surface of inorganic particles.
- the present invention provides the aforementioned affinity particles wherein said inorganic particles are selected from a group consisting of silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid, and having an average particle size of 20 nm to 500 ⁇ m and a specific gravity of 1.0 g/cm 3 or higher.
- the present invention provides the aforementioned affinity particles wherein said ligands are one, two, or more types of ligands chosen from a group consisting of various antibodies, antigens, enzymes, substrates, lectin, receptors, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
- the present invention provides a method of affinity separation of a target substance by using inorganic particles that includes (1) a first process whereby arbitrary ligands are bonded to the affinity particles of claim 1 or 2 , (2) a second process whereby the affinity particles prepared in the first process are dispersed in a liquid sample containing a target substance selectively captured by the arbitrary ligands, and (3) a third process whereby the target substance captured is recovered from the affinity particles.
- the present invention provides a method of affinity separation of a target substance by using inorganic particles that includes (1) a first process whereby the affinity particles of claim 3 are dispersed in a liquid sample containing a target substance selectively captured by the arbitrary ligands, and (2) a second process whereby the target substance captured is recovered from the affinity particles.
- the affinity particles of the present invention are used for detection of antibodies and protein, such as in the immunoprecipitation method and the latex agglutination method, the recovery process (2) is not required; detection can be done easily by visually observing changes in the dispersion state.
- the affinity particles of the present invention use ligands to capture only a certain target substance (the substance desired to be separated) and suppresses adsorption of other substances onto the particles, resulting in a very high separation selectivity. They also exhibit superior dispersion properties and make separation from liquid samples very easy, which makes it possible to separate the target substance easily and with high accuracy by using inexpensive inorganic powder particles for affinity particles.
- the target substance separation method of the present invention can effectively and easily separate the target substance to be separated in a short amount of time. Since substances have a tendency to adsorb onto foreign substances, conventional affinity particles have difficulties efficiently isolating only the target substance; however, it is possible to very efficiently prevent non-specific adsorption of other substances to the affinity particles and thus increase the purification yield by modifying the particle surface with phosphorylcholine groups.
- phosphorylcholine groups are extremely hydrophilic and they also improve the dispersion properties of the affinity particles in a liquid sample containing water.
- the affinity particles used in the present invention are composed of inorganic particles and therefore their specific gravity is high, which makes it easy to recover them by leaving the mixture at rest or by light centrifugation. These particles can be filled in a column as carriers and such a column can be used as an affinity column to recover a target substance.
- FIG. 1 is a schematic showing the difference between the protein capture selectivity of the affinity particles of the present invention and conventional affinity particles.
- FIG. 2 shows a chemical structure formula and an NMR spectrum of the chemical compound prepared in Synthesis example 1.
- FIG. 3 shows a chemical structure formula and an NMR spectrum of the chemical compound prepared in Synthesis example 2.
- FIG. 4 shows the result of the P quantification using the PC particles (A), (B), and (C) prepared in Synthetic example 5 and the Af particles (A), (B), and (C) prepared in Synthetic example 6.
- FIG. 5 is a 31P-CPMAS spectrum of the PC particles (A) prepared in Reference example 1.
- FIG. 6 is a FT-IR spectrum of the PC particles (A) prepared in Reference example 1.
- FIG. 7 is a 13C-CPMAS spectrum of the PC particles (A) prepared in Reference example 3.
- FIG. 8 is an evaluation of suppression of non-specific adsorption of proteins on the PC particles (A), (B), and (C) prepared in Reference example 1, 2, and 3.
- FIG. 9 is a selectivity evaluation of the Af particles (A) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Example 1.
- FIG. 10 is a selectivity evaluation of the Af particles (B) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Example 2.
- FIG. 11 is a selectivity evaluation of the Af particles (C) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Example 3.
- FIG. 12 is a selectivity evaluation of the Af particles (A) and (C) on goat anti-serum that was conducted in Examples 1 and 3.
- FIG. 13 is a selectivity evaluation of the Af particles (A) and (C) on anti-human hemoglobin in goat serum that was conducted in Examples 1 and 3.
- FIG. 14 is a selectivity evaluation of the Af particles (A) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Comparative example 1.
- An inorganic particle generally means any inorganic object having an average particle size of about 20 nm to 500 ⁇ m. for example, talc, kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, lepidolite, biotite, vermiculite, magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, tungstic acid metal salt, magnesium, silica, zeolite, barium sulfate, firing calcium sulfate (calcined gypsum), calcium phosphate, fluorine-apatite, hydroxy apatite, ceramic powder, metallic soaps (for example, myristic acid zinc, calcium palmitate, and aluminum stearate), boron nitride, cerium oxide, and gold colloid.
- talc kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, lepido
- Particularly preferable particles include silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid.
- Nonporous inorganic particles are more preferable than porous inorganic particles.
- the surface should preferably have reactive groups such as amino groups.
- Preferable affinity particles are those whose inorganic particles have an average particle size of 20 nm to 500 ⁇ m and a specific gravity of 1.0 g/cm 3 or higher.
- Examples include silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid.
- the selection is not limited as long as bonding with the ligand is possible.
- the covalent bond form include an amide, ester, urethane, ether, secondary amine, urea bond, and disulfide bond. Therefore, reactive groups for which ligands can take the corresponding covalent bond forms are preferable; examples include amino groups, hydroxyl groups, carboxyl groups, thiol groups, and aldehyde groups.
- preferable are an avidin-biotin, metal-chelating compound, etc. Therefore, adsorptive groups for which ligands can take the corresponding adsorptive forms are preferable; examples include avidin, biotin, and chelating compounds.
- a “ligand” means a substance that binds specifically to a certain target substance; examples include various antibodies, antigens, enzymes, substrates, receptors, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
- Examples of the various antibodies include IgG, IgM, IgA, IgD, IgE, and IgY
- examples of antigens include protein and polysaccharides
- examples of enzymes include glutathione-S-transferase
- examples of substrates include glutathione
- examples of receptors include hormone receptors and cytokine receptors
- examples of chelating compounds include nitrile triacetate
- examples of various metal ions include Ni 2+ , Co 2+ , Cu 2+ , Zn 2+ , and Fe 3+ .
- the essence of the present invention is to have the phosphorylcholine group represented by formula (1) covalently bonded onto the surface of inorganic particles and also for the inorganic particles to have reactive groups or adsorptive groups capable of bonding to ligands having specific affinity to a certain target substance that are directly present on their surface by means of covalent bonding or adsorption, there is no limitation on the selection of the preparation method; bonding can be done by any means.
- this does not include methods in which a polymer already having the phosphorylcholine group and reactive groups or adsorptive groups capable of bonding to ligands is used to simply coat the particle surface without chemical bonding. This is because the coating polymer can peel off and/or there may be an influence from the coating polymer.
- the affinity particles of the present invention can be prepared with the following method, for example.
- Step 1 The phosphorylcholine group represented by the following formula (1) and reactive groups or adsorptive groups capable of bonding to ligands are introduced onto the particles.
- the selection of the reactive group or adsorptive group is not limited; examples include an amino group, hydroxyl group, carboxyl group, and aldehyde group.
- Step 2 The phosphorylcholine group represented by formula (1) and the ligand are bonded to the reactive group or adsorptive group introduced onto the particles.
- Any chemical structure can exist between the phosphorylcholine group or ligand and the reactive group or adsorptive group. Examples of such arbitrary spacers include a methylene chain, oxyethylene chain, as well as an alkylene chain containing one or a plurality of amino groups.
- Step 1 Amino groups are introduced to any particle by using a prior art method or a method that will be developed in the future. Amino groups are directly introduced onto the particle surface.
- the amino group can be a primary amine or a secondary amine.
- Step 2 An aldehyde derivative or hydrate derivative obtained by the oxidative cleavage reaction of glycerophosphorylcholine is used in a reductive amination reaction to directly add phosphorylcholine groups to the surface of the particle having amino groups.
- a carboxyl derivative obtained by the oxidative cleavage reaction of glycerophosphorylcholine is used in an amidation reaction to directly add phosphorylcholine groups to the surface of the particles having amino groups.
- step 1 Examples of a prior art method for introducing amino groups to the particles (step 1) follow:
- Amino groups are introduced to the particle surface by means of a low temperature plasma in a nitrogen gas atmosphere. Specifically, the particles are put into a plasma reactor vessel and, after a vacuum pump is used to form a vacuum in the reactor vessel, nitrogen gas is introduced. Amino groups can be then introduced onto the particle surface by means of glow discharge. It is also possible to mechanically turn the plasma-treated inorganic material into particles. References related to the plasma treatment are shown below:
- the surface of the inorganic particles such as silanol-containing particles is treated with a surface modifier having amino groups, such as alkoxysilane, chlorosilane, and silazane.
- silica particles are treated with 3-aminopropyltrimethoxysilane, which has a primary amino group, to introduce amino groups.
- silica is soaked in a mixed solution of water and 2-propanol, and, after adding 3-aminopropyltrimethoxysilane, the temperature is raised to 100° C. and the reaction is carried out for six hours. After cooling down to room temperature, the silica is rinsed with methanol and dried to obtain particles that have amino groups directly introduced onto the silica surface.
- examples of the particles preferably treated with this method include particles composed of glass, alumina, talc, clay, aluminum, iron, mica, asbestos, titanium oxide, zinc flower, and iron oxide.
- the particle surface is treated with 1.3.5.7-tetramethylcyclotetrasiloxane and then Si—H groups introduced onto the surface are reacted with monomers having an amino group to obtain an aminated surface.
- mica and 1.3.5.7-tetramethylcyclotetrasiloxane are put into a desiccator and an aspirator is used to deaerate it.
- the reaction is carried out for 16 hours at 80° C., and the mica is taken out and dried at 120° C.
- the obtained mica is dispersed in ethanol, to which allylamine is added, and an ethanol solution of chloroplatinic acid is added, followed by two hours of stirring at 60° C.
- Various inorganic particles (mica, talc, kaolin, alumina, titanium oxide, zinc oxide, iron oxide, various inorganic pigments, etc.) are preferably treated.
- an amine-type monomer can be used.
- the amine-type monomer is not limited to allylamine as long as it has a reactive site such as polymerizable vinyl and acrylate, and an amino group.
- the amino group can be protected by a butoxycarbonyl group, benzyloxycarbonyl group or the like.
- a monomer having a functional group such as an epoxy group, to which an amino group can be easily introduced by means of, for example, a reaction with diamine can be used as well.
- step 2 a method for introducing phosphorylcholine groups onto the aminated particle surface (step 2) is described below.
- the particles are soaked in methanol, to which phosphatidylglyceroaldehyde is added, and the mixture is left alone for six hours at room temperature.
- Sodium cyanoborate is then added at 0° C., followed by overnight heating and stirring, to add a phosphorylcholine group to an amino group.
- the particles are rinsed with methanol and dried to obtain particles that have phosphorylcholine groups directly on the surface.
- protic solvents such as water, ethanol, and 2-propanol can be used in addition to methanol; the introduction rate tends to be higher when methanol is used.
- the particles directly having phosphorylcholine groups on the surface can be obtained by a method in which particles having amino groups are prepared and then a reductive amination reaction with a hydrate derivative or aldehyde derivative obtained by the oxidative cleavage reaction of glycerophosphorylcholine is used to directly add phosphorylcholine groups to the particle surface.
- This method has the following great advantages: the introduction rate of the phosphorylcholine group is high, and the surface of various inorganic particles can be modified.
- the aforementioned compound containing aldehyde is obtained by oxidative cleavage of the prior art glycerophosphorylcholine group by means of a prior art method, which is a very easy step.
- 1,2-diol is oxidized with an oxidant such as periodic acid, periodate, or bismuth trioxide to cleave the bond and obtain an aldehyde derivative.
- the reaction is usually carried out in water or an organic solvent containing water at a reaction temperature between 0° C. and room temperature.
- the aldehyde derivative may go through an equilibrium reaction in water to become a hydrate, but this does not affect the subsequent reaction with the amine.
- An example of a scheme for preparing a monofunctional aldehyde derivative containing a phosphorylcholine group is described below.
- the reductive amination reaction for bonding the aldehyde derivative (or hydrate derivative) obtained by the oxidative cleavage reaction of glycerophosphorylcholine to the amino groups of the particles can be carried out easily by stirring both of them in a solvent. This reaction is carried out by dissolving or dispersing these two in water or alcohol (a third organic solvent ingredient can be mixed in, too) to form an imine and reducing it with a reducing agent to obtain a secondary amine.
- a mild reducing agent such as sodium cyanoboronate is preferable, but other reducing agents can be used as long as the phosphorylcholine is stable.
- the reaction is usually carried out at 0° C. to room temperature, but heating may be done depending on the situation.
- n denotes an integer 1-12.
- Examples of the specific methods include a method in which the compound of formula (2) is reacted with thionyl chloride in N,N′-dimethylformamide to obtain an acid chloride, which is then reacted with particles having amino groups in N,N′-dimethylformamide to introduce the phosphorylcholine group represented by formula (1) by means of amide bonding.
- the compound of formula (2) can be synthesized by using the following scheme.
- the affinity particles described in claim 2 i.e. the particles that are inorganic particles directly having on their surface the phosphorylcholine groups represented by formula (1) and reactive groups or adsorptive groups to which the ligand can bond.
- the affinity particles described in claim 3 i.e. the inorganic particles directly having the phosphorylcholine group represented by formula (1) and the ligand on their surface, are obtained.
- the product form of the affinity particles described in claim 2 is such that the user can bond any ligand to them depending on the substance to be captured (target substance).
- the product form of the affinity particles described in claim 3 is such that the ligand is already bonded.
- the affinity particles described in claim 1 are affinity particles having at least the phosphorylcholine group of formula (1) on the particle surface and their product form is such that the user can bind any ligand to them depending on the substance to be captured (target substance), regardless of the presence or absence of the ligand or reactive group or adsorptive group that can bind to it.
- Affinity particles of any form are included as long as the phosphorylcholine group of formula (1) is present on the particle surface; for example, the forms described in claim 2 and claim 3 are included as well.
- this amino group is also possible to react this amino group with a compound having any functional group and use this functional group as the reactive group or adsorptive group to which the ligand can bind.
- Examples include glutaraldehyde, alkyl diimidate, acyl azides, and isocyanates.
- the ligand is a protein
- one aldehyde group of glutaraldehyde is reacted with an amino group on the inorganic particle and the other aldehyde group is reacted with an amino group in the protein, thus binding the protein.
- the hydroxyl groups (OH) present on the particle surface are used as they are to introduce the phosphorylcholine group and the ligand or reactive groups or adsorptive groups to which the ligand can bind.
- the affinity particles of the present invention are preferably prepared with this method.
- a chemical bond is formed by dehydration of the hydroxyl group on the particle surface and Si—OMe of the compound of the following formula (3) or (4). This chemical reaction proceeds very easily and quantitatively in most organic solvents if heating and refluxing are provided. Chemically and physically very stable phosphorylcholine groups can be introduced by means of this dehydration reaction, which is preferable.
- the phosphorylcholine group-containing compound represented by the following formula (3) or (4) is a new compound.
- OMe can be replaced by OEt or Cl. Up to two of the OMe's, OEt's, or Cl's to be bonded to Si can be replaced by a methyl group, ethyl group, propyl group, isopropyl group, or isobutyl group.
- the phosphorylcholine derivative shown in the following formula (5) is dissolved in distilled water.
- the phosphorylcholine derivative of the following formula (5) is a prior art chemical compound and commercially available.
- the procedure described above can be carried out in the exact same way even when m and n in the chemical compounds represented by formula (3) or (4) change.
- the reaction solvent is not limited in particular; in addition to methanol, which was mentioned above, water, alcohols such as ethanol, propanol, and butanol, and aprotic solvents such as DMF and DMSO can be used. Dehydrated solvents are preferable to prevent polymerization during the reaction; of these, dehydrated methanol is particularly preferable.
- the phosphorylcholine derivative shown in the following formula (5) is dissolved in a mixture of distilled water and acetonitrile.
- the phosphorylcholine derivative of the following formula (5) is a prior art chemical compound and commercially available.
- Thionyl chloride is then added to formula (7) in N,N′-dimethylformamide to turn it into an acid chloride, to which 0.5 equivalents of 3-aminopropyltrimethoxysilane and 2 equivalents of triethylamine are added.
- This mixed solution is stirred at room temperature for a prescribed amount of time to obtain an N,N′-dimethylformamide solution of formula (4).
- the procedure described above can be carried out in the same way even when m and n in the chemical compounds represented by formula (4) change.
- the reaction solvent is not limited in particular; in addition to N,N′-dimethylformamide, which was mentioned above, aprotic solvents such as acetonitrile, tetrahydrofuran, and dimethylsulfoxide can be used. It is preferable to use a dehydrated solvent to prevent polymerization during the reaction.
- the affinity particles described in claim 2 i.e. the particles that are inorganic particles directly having on their surface the phosphorylcholine groups represented by formula (1) and reactive groups or adsorptive groups to which the ligand can bond.
- the affinity particles described in claim 3 i.e. the inorganic particles directly having the phosphorylcholine group represented by formula (1) and the ligand on their surface, are obtained.
- the product form of the affinity particles described in claim 2 is such that the user can bond any ligand to them depending on the substance to be captured (target substance).
- the product form of the affinity particles described in claim 3 is such that the ligand is already bonded.
- the affinity particles described in claim 1 are affinity particles having at least the phosphorylcholine group of formula (1) on the particle surface and their product form is such that the user can bind any ligand to them depending on the protein to be captured (target substance), regardless of the presence or absence of the ligand or reactive group or adsorptive group that can bind to the ligand.
- Affinity particles of any form are included as long as the phosphorylcholine group of formula (1) is present on the particle surface; for example, the forms described in claim 2 and claim 3 are included as well.
- the ligand is a protein
- hydroxyl groups on the particles are activated by using cyanogen bromide. Amino groups in the protein are reacted with these to bind the protein.
- Step 1 Carboxyl groups are introduced to any particle by using a prior art method or a method that will be developed in the future. Carboxyl groups are directly introduced onto the particle surface.
- Step 2 It is also possible to react the phosphorylcholine-containing compound represented by formula (2) with the particles having carboxyl groups so as to form an acid amide bonding with the phosphorylcholine group and use the remaining carboxyl groups as reactive groups or adsorptive groups to which ligands can bind.
- step 1 Examples of a prior art method for introducing carboxyl groups to the particles (step 1) follow:
- the surface of the inorganic particles such as silanol-containing particles is treated with a surface modifier having carboxyl groups, such as alkoxysilane, chlorosilane, and silazane.
- silica particles are treated with triethoxysilylpropyl succinate anhydrate to introduce carboxyl groups.
- triethoxysilylpropyl succinate anhydrate is dissolved in N,N-dimethylformamide, to which distilled water and 4-dimethylaminopyridine is added, followed by stirring at room temperature for 16 hours to obtain a silane coupling agent having carboxylic acid represented in the following formula (3).
- This reaction is a hydrolysis reaction of succinic acid anhydrate using 4-dimethylaminopyridine.
- Silica particles are treated with the silane coupling agent having carboxyl groups to introduce carboxyl groups. Specifically, silica is soaked in a mixed solution of water and 2-propanol, and, after adding the silane coupling agent having carboxyl groups, the temperature is raised to 100° C. and the reaction is carried out for six hours. After cooling down to room temperature, the silica is rinsed with methanol and dried to obtain particles that have carboxyl groups directly introduced onto the silica surface.
- examples of the particles preferably treated with this method include particles composed of glass, alumina, talc, clay, aluminum, iron, mica, asbestos, titanium oxide, zinc flower, and iron oxide.
- the particle surface is treated with 1.3.5.7-tetramethylcyclotetrasiloxane and then Si—H groups introduced onto the surface are reacted with monomers having a carboxyl group to obtain a carboxylated surface.
- Various inorganic particles (mica, talc, kaolin, alumina, titanium oxide, zinc oxide, iron oxide, various inorganic pigments, etc.) are preferably treated.
- a carboxyl-type monomer can be used.
- the selection of the carboxyl-type monomer is not limited as long as it has a reactive site such as a carboxyl group, polymerizable vinyl and acryl.
- step 2 a method for introducing phosphorylcholine groups onto the carboxylated particle surface (step 2) is described below.
- these particles are the affinity particles described in claim 2 , i.e. the particles that are inorganic particles directly having on their surface the phosphorylcholine groups represented by formula (1) and reactive groups or adsorptive groups to which the ligand can bond.
- the affinity particles described in claim 3 i.e. the inorganic particles directly having the phosphorylcholine group represented by formula (1) and the ligand on their surface, are obtained.
- the product form of the affinity particles described in claim 2 is such that the user can bond any ligand to them depending on the substance to be captured (target substance).
- the product form of the affinity particles described in claim 3 is such that the ligand is already bonded.
- the affinity particles described in claim 1 are affinity particles having at least the phosphorylcholine group of formula (1) on the particle surface and their product form is such that the user can bind any ligand to them depending on the substance to be captured (target substance), regardless of the presence or absence of the ligand or reactive group or adsorptive group that can bind to the ligand.
- Affinity particles of any form are included as long as the phosphorylcholine group of formula (1) is present on the particle surface; for example, the forms described in claim 2 and claim 3 are included as well.
- the ligand is a protein
- inorganic particles having carboxyl groups on the surface are soaked in a solution of N-hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide to esterify the particle surface.
- Amino groups in the protein are reacted with these to bind the protein. It is also possible to react this hydroxyl group with a compound having any functional group and use this functional group as the reactive group or adsorptive group to which the ligand can bind.
- the affinity separation of a target substance of the present invention is carried out.
- the method of the present invention is a technological separation/purification method for a target substance in that high precision separation can be easily done by using inorganic particles.
- the method of the present invention contains the following 3 processes.
- the first process is omitted for the affinity particles to which the ligand is already bonded (claim 2 ) since this process has already been done for such particles.
- 1 ml of a PBS solution of any ligand and affinity particles that are inorganic particles having the phosphorylcholine group represented by formula (1) covalently bonded onto their surface and reactive groups or adsorptive groups to which the ligand can bind covalently bonded or adsorbed on their surface are put into a 2 ml eppen tube, followed by gentle shaking at 4° C. for 30 minutes. This is centrifuged for 5 minutes at 5000 rpm and the supernatant is discarded. The sample is cleaned by adding 1 ml of a PBS solution to it, gently shaking it, centrifuging it for 5 minutes at 5000 rpm, and discarding the supernatant. This cleaning operation is repeated 3 times.
- the affinity particles prepared in the first process are dispersed in a liquid sample containing the target substance that is selectively captured by any ligand, followed by gentle shaking for 30 minutes at 4° C. This is centrifuged for 5 minutes at 5000 rpm and the supernatant is discarded. The sample is cleaned by adding 1 ml of a PBS solution to it, gently shaking it, centrifuging it for 5 minutes at 5000 rpm, and discarding the supernatant. This cleaning operation is repeated 3 times.
- 1 ml of an elution buffer is added, followed by gentle shaking for 30 minutes at 4° C. to elute the target substance from the particles, and the supernatant is recovered.
- 1 ml of a PBS solution is added to it, followed by gentle shaking and centrifugation for 5 minutes at 5000 rpm, and the supernatant is recovered. This operation is repeated twice.
- FIG. 1 is a schematic showing the differences between the target substance capture selectivity of the affinity particles of the present invention and conventional affinity particles.
- the present invention is described in detail by referring to Examples.
- the present invention is not limited to these Examples.
- the phosphorylcholine groups introduced onto the particle surface can be verified and quantified by the FT-IR and element analysis.
- 1-alpha-glycerophosphorylcholine (6.29 g) was dissolved in 210 ml of distilled water and cooled in an ice water bath. Sodium periodate (10.23 g) was added, followed by five hours of stirring. The reaction fluid was concentrated under reduced pressure and dried under reduced pressure; methanol was then used to extract the target substance.
- the structure is shown in the following chemical formula (6).
- a 1H NMR spectrum of the compound of formula (6) is shown in FIG. 2 . Since the compound of formula (6) is in equilibrium with formula (9) in water, the actual spectrum reflects both formula (6) and formula (9).
- a 1H NMR spectrum of the compound of formula (7) is shown in FIG. 3 .
- PC Particles (A) that are Inorganic Particles Having Phosphorylcholine Groups Covalently Bonded onto Their Surface
- PC Particles (B) that are Inorganic Particles Having Phosphorylcholine Groups Covalently Bonded onto Their Surface
- FIG. 4 shows the P quantification measurements of the PC-treated particles (B) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4.
- the PC introduction level thus determined was 3.4 ⁇ mol/g-particles, which confirmed the introduction of PC groups onto the particle surface.
- PC Particles (C) that are Inorganic Particles Having Phosphorylcholine Groups Covalently Bonded onto Their Surface
- FIG. 4 shows the P quantification measurements of the PC-treated particles (C) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4.
- the PC introduction level thus determined was 7.3 ⁇ mol/g-particles, which confirmed the introduction of PC groups onto the particle surface.
- FIG. 5 A 13C-CPMAS spectrum and a 13C-PSTMAS spectrum of the PC particles (A) of Reference example 1 are shown in FIG. 5 .
- the PSTMAS spectrum selectively captures a spectrum of free moving molecular chains; this method is widely used for analysis of modifying chains on the particle surface.
- FIG. 5 a spectrum due to carbons in the phosphorylcholine group is observed at 54.2 ppm.
- FIG. 7 shows a FT-IR spectrum of the PC particles (C) of Reference example 3. Absorption specific to amide bonding is observed near 1650 cm ⁇ 1 .
- untreated particles 25 mg each of untreated silica gel particles having no phosphorylcholine group introduced used in Reference example 1 (abbreviated as “untreated particles”) and the PC particles (A), (B), and (C) prepared in Reference examples 1, 2, and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing the distilled water by means of centrifugation, 1 ml of albumin (100 ⁇ g/ml) or lysozyme (100 ⁇ g/ml) was added, followed by a 1 hour reaction at room temperature and cleaning by means of centrifugation/purification (5,000 g) 5 times with PBS.
- PC particles (B) and (C) showed even more suppressed adsorption of both albumin and lysozyme compared with untreated particles or PC particles (A).
- FIG. 4 shows the P quantification measurements of the Af particles (A) prepared in the aforementioned procedure using the surface modifier of Synthetic example 3.
- the PC introduction level thus determined was 2.7 ⁇ mol/g-particles, which confirmed the introduction of PC groups onto the particle surface.
- FIG. 4 shows the P quantification measurements of the Af particles (B) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4.
- the PC introduction level thus determined was 3.3 ⁇ mol/g-particles, which confirmed the introduction of PC groups onto the particle surface.
- Affinity Particles that are Inorganic Particles having Phosphorylcholine Groups and Amino Groups Covalently Bonded onto Their Surface
- FIG. 4 shows the P quantification measurements of the Af particles (C) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4.
- the PC introduction level thus determined was 6.3 ⁇ mol/g-particles, which confirmed the introduction of PC groups onto the particle surface.
- the affinity particles of claim 2 that have glutaraldehyde as reactive groups or adsorptive groups to which the ligand can bind were thus obtained.
- 1 ml of bovine albumin (1 mg/ml) or human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by 4 times of a centrifugation/purification (5,000 g) with PBS.
- This bovine albumin or human hemoglobin is the ligand. After this is the affinity separation method shown in claim 7 .
- Af particles (A) exhibited selectivity for human hemoglobin-HRP conjugated anti-human hemoglobin antibody. Also, Af particles (B) and Af particles (C) exhibited selectivity for both bovine albumin-HRP conjugated anti-bovine albumin antibody and human hemoglobin-HRP conjugated anti-human hemoglobin antibody.
- Goat anti-serum for human hemoglobin was used to conduct a selectivity test. 25 mg each of Af particles (A) and (C) prepared in Examples 1 and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing the distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium cyanotrihydroborate, for stabilizing the Schiff base, were added to these affinity particles and the reaction was carried out for 5 hours at room temperature, followed by a centrifugation/purification (5,000 g) operation 5 times using MQ water for cleaning.
- Af particles (A) and (C) prepared in Examples 1 and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing the distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium
- the affinity particles of claim 2 that have glutaraldehyde as reactive groups or adsorptive groups to which the ligand can bind were thus obtained.
- 1 ml human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by centrifugation/purification (5,000 g) 4 times with PBS. This human hemoglobin is the ligand.
- 1 ml of ethanolamine hydrochloride (0.5 M, pH 7.1) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 hour at room.
- the goat anti-serum mixed with anti-human hemoglobin was used to conduct a selectivity test. 25 mg each of Af particles (A) and (C) prepared in Examples 1 and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium cyanotrihydroborate, for stabilizing the Schiff base, were added to these affinity particles and the reaction was carried out for 5 hours at room temperature, followed by a centrifugation/purification (5,000 g) operation 5 times using MQ water for cleaning.
- Af particles (A) and (C) prepared in Examples 1 and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium
- the affinity particles of claim 2 that have glutaraldehyde as reactive groups or adsorptive groups to which the ligand can bind were thus obtained.
- 1 ml human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by a centrifugation/purification (5,000 g) 4 times with PBS. This human hemoglobin is the ligand. After this is the affinity separation method shown in claim 7 .
- Glutaraldehyde is the reactive group or adsorptive group that can bind to the ligand.
- bovine albumin 1 mg/ml or human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by centrifugation/purification (5,000 g) 4 times with PBS.
- This bovine albumin or human hemoglobin is the ligand.
- 1 ml of ethanolamine hydrochloride (0.5 M, pH 7.1) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 hour at room temperature to deactivate the remaining glutaraldehyde, followed by centrifugation/purification (5,000 g) 4 times with PBS to obtain the affinity particles of claim 3 .
- the affinity particles of the present invention capture only the target protein that is desired to be separated and therefore they exhibit very high selectivity. They also exhibit superior dispersion properties and make separation from liquid samples very easy. Since a target substance can be separated easily with high accuracy using affinity particles made from inexpensive inorganic particles, the present invention is useful in bio-industries where a highly accurate separation and detection of the target substance is required.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
The present invention is affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic powder and also by having ligands having specific affinity with a certain target substance covalently bonded or adsorbed onto the surface of inorganic powder.
The object of the present invention is to provide an affinity separation method that uses affinity particles utilizing inexpensive inorganic particles and is capable of separating the target substance easily and with high accuracy.
The object of the present invention is to provide an affinity separation method that uses affinity particles utilizing inexpensive inorganic particles and is capable of separating the target substance easily and with high accuracy.
Description
- The present invention relates to affinity particles and an affinity separation method. More specifically, it relates to affinity particles utilizing inorganic particles and an affinity separation method that allows easy and highly precise separation of the target substance. The present invention is very useful in various separation, purification, and testing methods including latex agglutination methods and immunoprecipitation methods that allow easy and highly sensitive detection of the target substance.
- Conventionally, column chromatography has been used for separation and purification of biological substances. However, column separation has some fatal problems as described in the following (1) to (3):
- (1) Many kinds of columns have to be used to obtain the target substance, resulting in a poor purification efficiency.
- (2) A verification test is required to make sure the target substance is contained in the fractionated ingredients, which means purification is time consuming.
- (3) Because of the large purification loss, a large quantity of the sample is required.
- On the other hand, for separation and purification of the target substances, affinity particles and affinity columns supporting ligands are used (
Patent Document 1 and Patent Document 2). - However, separation and purification using affinity columns have the following problems:
- (1) The desired target substance is not selectively separated. That is, in addition to the target substance captured by the ligand, unwanted substances are also adsorbed onto the column.
- (2) The capture efficiency is low, which means a large quantity of the liquid sample is required.
- The affinity separation method in which affinity particles are dispersed in a liquid sample for separation uses agarose and such (Non-patent Document 1), but this method has the following problems:
- (1) The desired target substance is not selectively separated. That is, in addition to the target substance captured by the ligand, unwanted target substances are also adsorbed onto the affinity particles.
- (2) The specific gravity is small, which makes the separation of the affinity particles difficult.
- (3) The carrier is easily disintegrated, which leads to poor durability.
- On the other hand, inorganic particles adsorb more substances than organic particles do, therefore those skilled in the art didn't think of using inorganic particles for affinity particles.
- Patent Document 1: Japanese Patent Publication H8-26076
- Patent Document 2: Japanese Patent Laid-Open 2002-511141 bulletin
- Non-patent Document 1: Bioconjugate Chem.; 2002; 13(2); 163-166
- [Problem that the Present Invention Aims to Solve]
- The object of the present invention is to provide a groundbreaking affinity separation method that uses affinity particles utilizing inexpensive inorganic particles and is capable of separating the target substance easily and with high accuracy. The present invention is very useful in various separation, purification, and testing methods including latex agglutination methods and immunoprecipitation methods that allow easy and highly sensitive detection of the target substance.
- [Means to Solve the Problem]
-
- Also, the present invention provides affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having reactive groups or adsorptive groups, which are capable of bonding with ligands having specific affinity with a certain target substance, covalently bonded or adsorbed onto the surface of inorganic particles.
- Furthermore, the present invention provides affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having ligands having specific affinity with a certain target substance covalently bonded or adsorbed onto the surface of inorganic particles.
[Chemical formula 6] - Also, the present invention provides the aforementioned affinity particles wherein said inorganic particles are selected from a group consisting of silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid, and having an average particle size of 20 nm to 500 μm and a specific gravity of 1.0 g/cm3 or higher.
- Furthermore, the present invention provides the aforementioned affinity particles wherein said ligands are one, two, or more types of ligands chosen from a group consisting of various antibodies, antigens, enzymes, substrates, lectin, receptors, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
- Also, the present invention provides a method of affinity separation of a target substance by using inorganic particles that includes (1) a first process whereby arbitrary ligands are bonded to the affinity particles of
claim - Furthermore, the present invention provides a method of affinity separation of a target substance by using inorganic particles that includes (1) a first process whereby the affinity particles of
claim 3 are dispersed in a liquid sample containing a target substance selectively captured by the arbitrary ligands, and (2) a second process whereby the target substance captured is recovered from the affinity particles. When the affinity particles of the present invention are used for detection of antibodies and protein, such as in the immunoprecipitation method and the latex agglutination method, the recovery process (2) is not required; detection can be done easily by visually observing changes in the dispersion state. - [Effects of the Invention]
- The affinity particles of the present invention use ligands to capture only a certain target substance (the substance desired to be separated) and suppresses adsorption of other substances onto the particles, resulting in a very high separation selectivity. They also exhibit superior dispersion properties and make separation from liquid samples very easy, which makes it possible to separate the target substance easily and with high accuracy by using inexpensive inorganic powder particles for affinity particles.
- That is, the target substance separation method of the present invention can effectively and easily separate the target substance to be separated in a short amount of time. Since substances have a tendency to adsorb onto foreign substances, conventional affinity particles have difficulties efficiently isolating only the target substance; however, it is possible to very efficiently prevent non-specific adsorption of other substances to the affinity particles and thus increase the purification yield by modifying the particle surface with phosphorylcholine groups.
- Also, phosphorylcholine groups are extremely hydrophilic and they also improve the dispersion properties of the affinity particles in a liquid sample containing water.
- Furthermore, conventional particles tend to aggregate in the presence of salts and therefore the purification efficiency decreases when the target substance is to be isolated from serum because of aggregation due to various salts in serum; however, the affinity particles of the present invention don't aggregate significantly even under the presence of salts, which makes it possible to recover the target substance efficiently.
- The affinity particles used in the present invention are composed of inorganic particles and therefore their specific gravity is high, which makes it easy to recover them by leaving the mixture at rest or by light centrifugation. These particles can be filled in a column as carriers and such a column can be used as an affinity column to recover a target substance.
-
FIG. 1 is a schematic showing the difference between the protein capture selectivity of the affinity particles of the present invention and conventional affinity particles. -
FIG. 2 shows a chemical structure formula and an NMR spectrum of the chemical compound prepared in Synthesis example 1. -
FIG. 3 shows a chemical structure formula and an NMR spectrum of the chemical compound prepared in Synthesis example 2. -
FIG. 4 shows the result of the P quantification using the PC particles (A), (B), and (C) prepared in Synthetic example 5 and the Af particles (A), (B), and (C) prepared in Synthetic example 6. -
FIG. 5 is a 31P-CPMAS spectrum of the PC particles (A) prepared in Reference example 1. -
FIG. 6 is a FT-IR spectrum of the PC particles (A) prepared in Reference example 1. -
FIG. 7 is a 13C-CPMAS spectrum of the PC particles (A) prepared in Reference example 3. -
FIG. 8 is an evaluation of suppression of non-specific adsorption of proteins on the PC particles (A), (B), and (C) prepared in Reference example 1, 2, and 3. -
FIG. 9 is a selectivity evaluation of the Af particles (A) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Example 1. -
FIG. 10 is a selectivity evaluation of the Af particles (B) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Example 2. -
FIG. 11 is a selectivity evaluation of the Af particles (C) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Example 3. -
FIG. 12 is a selectivity evaluation of the Af particles (A) and (C) on goat anti-serum that was conducted in Examples 1 and 3. -
FIG. 13 is a selectivity evaluation of the Af particles (A) and (C) on anti-human hemoglobin in goat serum that was conducted in Examples 1 and 3. -
FIG. 14 is a selectivity evaluation of the Af particles (A) on the anti-bovine albumin antibody and anti-human hemoglobin antibody that was conducted in Comparative example 1. - The present invention is described in detail below.
- “Inorganic Particles”
- The selection of the inorganic particles that constitute the affinity particles is not limited in particular in the present invention. “An inorganic particle” generally means any inorganic object having an average particle size of about 20 nm to 500 μm. for example, talc, kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, lepidolite, biotite, vermiculite, magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, tungstic acid metal salt, magnesium, silica, zeolite, barium sulfate, firing calcium sulfate (calcined gypsum), calcium phosphate, fluorine-apatite, hydroxy apatite, ceramic powder, metallic soaps (for example, myristic acid zinc, calcium palmitate, and aluminum stearate), boron nitride, cerium oxide, and gold colloid.
- Particularly preferable particles include silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid. Nonporous inorganic particles are more preferable than porous inorganic particles.
- Since the phosphorylcholine group represented by the aforementioned formula (1) and reactive groups or adsorptive groups that are capable of bonding with ligands are to be introduced onto the particle surface by means of covalent bonding, the surface should preferably have reactive groups such as amino groups.
- Preferable affinity particles are those whose inorganic particles have an average particle size of 20 nm to 500 μm and a specific gravity of 1.0 g/cm3 or higher.
- Examples include silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid.
- “Reactive Groups or Adsorptive Groups to Which the Ligand can Bind”
- The selection is not limited as long as bonding with the ligand is possible. Preferable examples of the covalent bond form include an amide, ester, urethane, ether, secondary amine, urea bond, and disulfide bond. Therefore, reactive groups for which ligands can take the corresponding covalent bond forms are preferable; examples include amino groups, hydroxyl groups, carboxyl groups, thiol groups, and aldehyde groups. Also, for the adsorption form, preferable are an avidin-biotin, metal-chelating compound, etc. Therefore, adsorptive groups for which ligands can take the corresponding adsorptive forms are preferable; examples include avidin, biotin, and chelating compounds.
- “Ligands”
- In the present invention, a “ligand” means a substance that binds specifically to a certain target substance; examples include various antibodies, antigens, enzymes, substrates, receptors, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions. Examples of the various antibodies include IgG, IgM, IgA, IgD, IgE, and IgY, examples of antigens include protein and polysaccharides, examples of enzymes include glutathione-S-transferase, examples of substrates include glutathione, examples of receptors include hormone receptors and cytokine receptors, examples of chelating compounds include nitrile triacetate, and examples of various metal ions include Ni2+, Co2+, Cu2+, Zn2+, and Fe3+.
- “A Method of Preparing the Affinity Particles of the Present Invention”
- Since the essence of the present invention is to have the phosphorylcholine group represented by formula (1) covalently bonded onto the surface of inorganic particles and also for the inorganic particles to have reactive groups or adsorptive groups capable of bonding to ligands having specific affinity to a certain target substance that are directly present on their surface by means of covalent bonding or adsorption, there is no limitation on the selection of the preparation method; bonding can be done by any means.
- However, as mentioned earlier, this does not include methods in which a polymer already having the phosphorylcholine group and reactive groups or adsorptive groups capable of bonding to ligands is used to simply coat the particle surface without chemical bonding. This is because the coating polymer can peel off and/or there may be an influence from the coating polymer.
- The affinity particles of the present invention can be prepared with the following method, for example.
- Step 1: The phosphorylcholine group represented by the following formula (1) and reactive groups or adsorptive groups capable of bonding to ligands are introduced onto the particles. The selection of the reactive group or adsorptive group is not limited; examples include an amino group, hydroxyl group, carboxyl group, and aldehyde group.
- Step 2: The phosphorylcholine group represented by formula (1) and the ligand are bonded to the reactive group or adsorptive group introduced onto the particles. Any chemical structure (spacer) can exist between the phosphorylcholine group or ligand and the reactive group or adsorptive group. Examples of such arbitrary spacers include a methylene chain, oxyethylene chain, as well as an alkylene chain containing one or a plurality of amino groups.
- “When the Reactive Group or Adsorptive Group on the Particle Surface is an Amino Group”
- Step 1: Amino groups are introduced to any particle by using a prior art method or a method that will be developed in the future. Amino groups are directly introduced onto the particle surface. The amino group can be a primary amine or a secondary amine.
- Step 2: An aldehyde derivative or hydrate derivative obtained by the oxidative cleavage reaction of glycerophosphorylcholine is used in a reductive amination reaction to directly add phosphorylcholine groups to the surface of the particle having amino groups.
- Not all the amino groups are bonded with the phosphorylcholine group (the reaction level is controlled) so that the remaining amino groups are available as substituents for the ligand to bind to.
- Or, a carboxyl derivative obtained by the oxidative cleavage reaction of glycerophosphorylcholine is used in an amidation reaction to directly add phosphorylcholine groups to the surface of the particles having amino groups.
- Not all the amino groups are bonded with the phosphorylcholine group (the reaction level is controlled) so that the remaining amino groups are available as substituents for the ligand to bind to.
- “A Method of Introducing Amino Groups onto the Particle Surface”
- Examples of a prior art method for introducing amino groups to the particles (step 1) follow:
- 1. Introduction of Amino Groups by Means of a Surface Reaction via a Plasma Treatment
- Amino groups are introduced to the particle surface by means of a low temperature plasma in a nitrogen gas atmosphere. Specifically, the particles are put into a plasma reactor vessel and, after a vacuum pump is used to form a vacuum in the reactor vessel, nitrogen gas is introduced. Amino groups can be then introduced onto the particle surface by means of glow discharge. It is also possible to mechanically turn the plasma-treated inorganic material into particles. References related to the plasma treatment are shown below:
- 1. M. Muller, C. oehr Plasma aminofunctionalisation of PVDF microfiltration membranes: comparison of the in plasma modifications with a grafting method using ESCA and an amino-selective fluorescent probe Surface and Coatings Technology 116-119 (1999) 802-807
- 2. Lidija Tusek, Mirko Nitschke, Carsten Werner, Karin Stana-Kleinschek, Volker Ribitsch Surface characterization of NH3 plasma treated
polyamide 6 foils Colloids and Surfaces A: Physicochem. Eng. Aspects 195 (2001) 81-95 - 3. Fabienne Poncin-Epaillard, Jean-Claude Brosse, Thierry Falher Reactivity of surface groups formed onto a plasma treated poly (propylene) film Macromol. Chem. Phys. 200. 989-996 (1999)
2. Introduction of Amino Groups by Means of a Surface Modifier - The surface of the inorganic particles such as silanol-containing particles is treated with a surface modifier having amino groups, such as alkoxysilane, chlorosilane, and silazane.
- For example, silica particles are treated with 3-aminopropyltrimethoxysilane, which has a primary amino group, to introduce amino groups. Specifically, silica is soaked in a mixed solution of water and 2-propanol, and, after adding 3-aminopropyltrimethoxysilane, the temperature is raised to 100° C. and the reaction is carried out for six hours. After cooling down to room temperature, the silica is rinsed with methanol and dried to obtain particles that have amino groups directly introduced onto the silica surface. In addition to silica, examples of the particles preferably treated with this method include particles composed of glass, alumina, talc, clay, aluminum, iron, mica, asbestos, titanium oxide, zinc flower, and iron oxide.
- 3. Introduction of Amino Groups by Means of the Silicone Vapor Phase Treatment (Refer to Japanese Patent Publication No. H1-54379, Japanese Patent Publication No. H1-54380 bulletin, and Japanese Patent Publication No. H1-54381 Bulletin.)
- The particle surface is treated with 1.3.5.7-tetramethylcyclotetrasiloxane and then Si—H groups introduced onto the surface are reacted with monomers having an amino group to obtain an aminated surface. For example, mica and 1.3.5.7-tetramethylcyclotetrasiloxane are put into a desiccator and an aspirator is used to deaerate it. The reaction is carried out for 16 hours at 80° C., and the mica is taken out and dried at 120° C. The obtained mica is dispersed in ethanol, to which allylamine is added, and an ethanol solution of chloroplatinic acid is added, followed by two hours of stirring at 60° C. After the reaction is completed, filtration, ethanol rinsing, and reduced-pressure drying is carried out to obtain aminated mica. Various inorganic particles (mica, talc, kaolin, alumina, titanium oxide, zinc oxide, iron oxide, various inorganic pigments, etc.) are preferably treated.
- For the monomer to be used in this method, an amine-type monomer can be used. The amine-type monomer is not limited to allylamine as long as it has a reactive site such as polymerizable vinyl and acrylate, and an amino group. The amino group can be protected by a butoxycarbonyl group, benzyloxycarbonyl group or the like.
- In addition to an amine-type monomer, a monomer having a functional group such as an epoxy group, to which an amino group can be easily introduced by means of, for example, a reaction with diamine, can be used as well.
- “A Method for Introducing Phosphorylcholine Groups onto the Particles Having Amino Groups”
- Next, a method for introducing phosphorylcholine groups onto the aminated particle surface (step 2) is described below.
- The particles are soaked in methanol, to which phosphatidylglyceroaldehyde is added, and the mixture is left alone for six hours at room temperature. Sodium cyanoborate is then added at 0° C., followed by overnight heating and stirring, to add a phosphorylcholine group to an amino group. The particles are rinsed with methanol and dried to obtain particles that have phosphorylcholine groups directly on the surface. For the reaction solvent, protic solvents such as water, ethanol, and 2-propanol can be used in addition to methanol; the introduction rate tends to be higher when methanol is used.
-
- As described above, the particles directly having phosphorylcholine groups on the surface can be obtained by a method in which particles having amino groups are prepared and then a reductive amination reaction with a hydrate derivative or aldehyde derivative obtained by the oxidative cleavage reaction of glycerophosphorylcholine is used to directly add phosphorylcholine groups to the particle surface.
- This method has the following great advantages: the introduction rate of the phosphorylcholine group is high, and the surface of various inorganic particles can be modified.
- The aforementioned compound containing aldehyde is obtained by oxidative cleavage of the prior art glycerophosphorylcholine group by means of a prior art method, which is a very easy step. For example, 1,2-diol is oxidized with an oxidant such as periodic acid, periodate, or bismuth trioxide to cleave the bond and obtain an aldehyde derivative. The reaction is usually carried out in water or an organic solvent containing water at a reaction temperature between 0° C. and room temperature. The aldehyde derivative may go through an equilibrium reaction in water to become a hydrate, but this does not affect the subsequent reaction with the amine. An example of a scheme for preparing a monofunctional aldehyde derivative containing a phosphorylcholine group is described below.
- The reductive amination reaction for bonding the aldehyde derivative (or hydrate derivative) obtained by the oxidative cleavage reaction of glycerophosphorylcholine to the amino groups of the particles can be carried out easily by stirring both of them in a solvent. This reaction is carried out by dissolving or dispersing these two in water or alcohol (a third organic solvent ingredient can be mixed in, too) to form an imine and reducing it with a reducing agent to obtain a secondary amine. For the reducing agent, a mild reducing agent such as sodium cyanoboronate is preferable, but other reducing agents can be used as long as the phosphorylcholine is stable. The reaction is usually carried out at 0° C. to room temperature, but heating may be done depending on the situation.
-
- n denotes an integer 1-12.
- Examples of the specific methods include a method in which the compound of formula (2) is reacted with thionyl chloride in N,N′-dimethylformamide to obtain an acid chloride, which is then reacted with particles having amino groups in N,N′-dimethylformamide to introduce the phosphorylcholine group represented by formula (1) by means of amide bonding.
- The compound of formula (2) can be synthesized by using the following scheme.
- “Reactive Groups or Adsorptive Groups to Which Ligands Can Bind”
- Not all the amino groups are bonded with the phosphorylcholine group (the reaction level is controlled) so that the remaining amino groups are available as reactive groups or adsorptive groups for the ligand to bind to. These particles are the affinity particles described in
claim 2, i.e. the particles that are inorganic particles directly having on their surface the phosphorylcholine groups represented by formula (1) and reactive groups or adsorptive groups to which the ligand can bond. When the ligand is bonded to these remaining amino groups, the affinity particles described inclaim 3, i.e. the inorganic particles directly having the phosphorylcholine group represented by formula (1) and the ligand on their surface, are obtained. - The product form of the affinity particles described in
claim 2 is such that the user can bond any ligand to them depending on the substance to be captured (target substance). The product form of the affinity particles described inclaim 3 is such that the ligand is already bonded. The affinity particles described inclaim 1 are affinity particles having at least the phosphorylcholine group of formula (1) on the particle surface and their product form is such that the user can bind any ligand to them depending on the substance to be captured (target substance), regardless of the presence or absence of the ligand or reactive group or adsorptive group that can bind to it. Affinity particles of any form are included as long as the phosphorylcholine group of formula (1) is present on the particle surface; for example, the forms described inclaim 2 andclaim 3 are included as well. - In the aforementioned reaction, leaving some amino groups as reactive groups or adsorptive groups to which the ligand can bind can be made possible, for example, by adjusting the reaction quantity or by a competitive reaction of 3-aminopropyl trimethoxysilane and 3-aminopropyl trimethoxysilane to which the phosphorylcholine group is introduced.
- It is also possible to react this amino group with a compound having any functional group and use this functional group as the reactive group or adsorptive group to which the ligand can bind. Examples include glutaraldehyde, alkyl diimidate, acyl azides, and isocyanates.
- In a scheme in which 3-aminopropyl trimethoxysilane is used for the aforementioned surface modifier, it is also possible to adjust the reaction quantity of the surface modifier to leave some hydroxyl groups (OH) on the particle surface and use these remaining OH groups as reactive groups or adsorptive groups to which the ligand can bind.
- “A Method of Binding the Ligand to the Particles Having Amino Groups”
- When the ligand is a protein, one aldehyde group of glutaraldehyde is reacted with an amino group on the inorganic particle and the other aldehyde group is reacted with an amino group in the protein, thus binding the protein.
- “When the Reactive Group or Adsorptive Group on the Particle Surface is a Hydroxyl Group”
- Since most inorganic particles have hydroxyl groups on their surface, no reactive group or adsorptive group to which the ligand can bind, such as amino groups as mentioned above, needs to be introduced; the hydroxyl groups (OH) present on the particle surface are used as they are to introduce the phosphorylcholine group and the ligand or reactive groups or adsorptive groups to which the ligand can bind. The affinity particles of the present invention are preferably prepared with this method.
- “A Method for Introducing Phosphorylcholine Groups onto the Particles Having Hydroxyl Groups”
- A chemical bond is formed by dehydration of the hydroxyl group on the particle surface and Si—OMe of the compound of the following formula (3) or (4). This chemical reaction proceeds very easily and quantitatively in most organic solvents if heating and refluxing are provided. Chemically and physically very stable phosphorylcholine groups can be introduced by means of this dehydration reaction, which is preferable. The phosphorylcholine group-containing compound represented by the following formula (3) or (4) is a new compound.
- In this formula, m denotes 2-6 and n denotes 1-4. OMe can be replaced by OEt or Cl. Up to two of the OMe's, OEt's, or Cl's to be bonded to Si can be replaced by a methyl group, ethyl group, propyl group, isopropyl group, or isobutyl group.
- “A Method of Preparing the Phosphorylcholine Group-Containing Chemical Compound of Formula (3)”
-
- An aqueous solution of the chemical compound of formula (5) is cooled in an ice water bath; then sodium periodate is added, followed by five hours of stirring. The reaction fluid is concentrated under reduced pressure and dried under reduced pressure; methanol is used to extract a phosphorylcholine derivative having an aldehyde group shown in the following formula (6).
- 0.5 equivalents of 3-aminopropyltrimethoxysilane is added to the methanol solution of formula (6). This mixed solution is stirred for a prescribed amount of time at room temperature and cooled with ice; an appropriate amount of sodium cyanohydroborate is then added and the temperature is returned back to room temperature, followed by 16 hours of stirring. During this time dry nitrogen is continued to be fed through the reaction vessel. After filtering the precipitate, a methanol solution of formula (3) and/or (4) is obtained.
- The procedure described above can be carried out in the exact same way even when m and n in the chemical compounds represented by formula (3) or (4) change. The procedure shown here is for m=3 and n=2. The reaction solvent is not limited in particular; in addition to methanol, which was mentioned above, water, alcohols such as ethanol, propanol, and butanol, and aprotic solvents such as DMF and DMSO can be used. Dehydrated solvents are preferable to prevent polymerization during the reaction; of these, dehydrated methanol is particularly preferable.
- If a methoxy group (OMe) in formula (3) or (4) is replaced by an ethoxy group (OEt), then the reaction is carried out by using ethanol instead of methanol; if it is replaced by Cl, then dimethylformamide or dimethylsulfoxide is used instead.
- Furthermore, even when one or two of the OMe groups, OEt, or Cl's to be bonded to Si are replaced by a methyl group, ethyl group, propyl group, butyl group, isopropyl group, or isobutyl group, the preparation can be carried out in exactly the same manner as described above.
- “A Method of Preparing the Phosphorylcholine Group-Containing Chemical Compound of Formula (4)”
-
- An aqueous solution of the chemical compound of formula (5) is cooled in an ice water bath; sodium periodate and ruthenium trichloride are added, followed by three hours of stirring. The reaction fluid is concentrated under reduced pressure and dried under reduced pressure; methanol is used to extract a phosphorylcholine derivative having an carboxyl group shown in the following formula (7).
- Thionyl chloride is then added to formula (7) in N,N′-dimethylformamide to turn it into an acid chloride, to which 0.5 equivalents of 3-aminopropyltrimethoxysilane and 2 equivalents of triethylamine are added. This mixed solution is stirred at room temperature for a prescribed amount of time to obtain an N,N′-dimethylformamide solution of formula (4).
- The procedure described above can be carried out in the same way even when m and n in the chemical compounds represented by formula (4) change. The procedure shown here is for m=3 and n=2. The reaction solvent is not limited in particular; in addition to N,N′-dimethylformamide, which was mentioned above, aprotic solvents such as acetonitrile, tetrahydrofuran, and dimethylsulfoxide can be used. It is preferable to use a dehydrated solvent to prevent polymerization during the reaction.
- Furthermore, even when one or two of the OMe groups, OEt, or Cl's to be bonded to Si are replaced by a methyl group, ethyl group, propyl group, isopropyl group, butyl group, or isobutyl group, the preparation can be carried out in exactly the same manner as described above.
- “Reactive Groups or Adsorptive Groups to Which Ligands can Bind”
- Not all the hydroxyl groups are bonded with the phosphorylcholine group (the reaction level is controlled) so that the remaining hydroxyl groups are available as reactive groups or adsorptive groups for the ligand to bind to. These particles are the affinity particles described in
claim 2, i.e. the particles that are inorganic particles directly having on their surface the phosphorylcholine groups represented by formula (1) and reactive groups or adsorptive groups to which the ligand can bond. When the ligand is bonded to these remaining hydroxyl groups, the affinity particles described inclaim 3, i.e. the inorganic particles directly having the phosphorylcholine group represented by formula (1) and the ligand on their surface, are obtained. - The product form of the affinity particles described in
claim 2 is such that the user can bond any ligand to them depending on the substance to be captured (target substance). The product form of the affinity particles described inclaim 3 is such that the ligand is already bonded. The affinity particles described inclaim 1 are affinity particles having at least the phosphorylcholine group of formula (1) on the particle surface and their product form is such that the user can bind any ligand to them depending on the protein to be captured (target substance), regardless of the presence or absence of the ligand or reactive group or adsorptive group that can bind to the ligand. Affinity particles of any form are included as long as the phosphorylcholine group of formula (1) is present on the particle surface; for example, the forms described inclaim 2 andclaim 3 are included as well. - “A Method of Binding the Ligand to the Particles Having Hydroxyl Groups”
- When the ligand is a protein, hydroxyl groups on the particles are activated by using cyanogen bromide. Amino groups in the protein are reacted with these to bind the protein.
- It is also possible to react this hydroxyl group with a compound having any functional group and use this functional group as the reactive group or adsorptive group to which the ligand can bind.
- “When the Reactive Group or Adsorptive Group on the Particle Surface is a Carboxyl Group”
- Step 1: Carboxyl groups are introduced to any particle by using a prior art method or a method that will be developed in the future. Carboxyl groups are directly introduced onto the particle surface.
- Step 2: It is also possible to react the phosphorylcholine-containing compound represented by formula (2) with the particles having carboxyl groups so as to form an acid amide bonding with the phosphorylcholine group and use the remaining carboxyl groups as reactive groups or adsorptive groups to which ligands can bind.
-
- Examples of a prior art method for introducing carboxyl groups to the particles (step 1) follow:
- 1. Introduction of Carboxyl Groups by Means of a Surface Modifier
- The surface of the inorganic particles such as silanol-containing particles is treated with a surface modifier having carboxyl groups, such as alkoxysilane, chlorosilane, and silazane.
- For example, silica particles are treated with triethoxysilylpropyl succinate anhydrate to introduce carboxyl groups. Specifically, triethoxysilylpropyl succinate anhydrate is dissolved in N,N-dimethylformamide, to which distilled water and 4-dimethylaminopyridine is added, followed by stirring at room temperature for 16 hours to obtain a silane coupling agent having carboxylic acid represented in the following formula (3). This reaction is a hydrolysis reaction of succinic acid anhydrate using 4-dimethylaminopyridine.
- Silica particles are treated with the silane coupling agent having carboxyl groups to introduce carboxyl groups. Specifically, silica is soaked in a mixed solution of water and 2-propanol, and, after adding the silane coupling agent having carboxyl groups, the temperature is raised to 100° C. and the reaction is carried out for six hours. After cooling down to room temperature, the silica is rinsed with methanol and dried to obtain particles that have carboxyl groups directly introduced onto the silica surface. In addition to silica, examples of the particles preferably treated with this method include particles composed of glass, alumina, talc, clay, aluminum, iron, mica, asbestos, titanium oxide, zinc flower, and iron oxide.
- 2. Introduction of Carboxyl Groups by Means of the Silicone Vapor Phase Treatment (Refer to Japanese Patent Publication No. H1-54379, Japanese Patent Publication No. H1-54380 Bulletin, and Japanese Patent Publication No. H1-54381 Bulletin.)
- The particle surface is treated with 1.3.5.7-tetramethylcyclotetrasiloxane and then Si—H groups introduced onto the surface are reacted with monomers having a carboxyl group to obtain a carboxylated surface. Various inorganic particles (mica, talc, kaolin, alumina, titanium oxide, zinc oxide, iron oxide, various inorganic pigments, etc.) are preferably treated.
- For the monomer to be used in this method, a carboxyl-type monomer can be used. The selection of the carboxyl-type monomer is not limited as long as it has a reactive site such as a carboxyl group, polymerizable vinyl and acryl.
- “A Method for Introducing Phosphorylcholine Groups onto the Particles Having Carboxyl Groups”
- Next, a method for introducing phosphorylcholine groups onto the carboxylated particle surface (step 2) is described below.
- When particles having carboxyl groups on the surface are soaked in a solution of N-hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide, the particle surface is coated with active ester groups. A solution of the phosphorylcholine derivative having an amino group represented by formula (7) is added to this to introduce phosphorylcholine groups.
- “Reactive Groups or Adsorptive Groups to Which Ligands can Bind”
- Not all the carboxyl groups are bonded with the phosphorylcholine group (the reaction level is controlled) so that the remaining carboxyl groups are available as reactive groups or adsorptive groups for the ligand to bind to. These particles are the affinity particles described in
claim 2, i.e. the particles that are inorganic particles directly having on their surface the phosphorylcholine groups represented by formula (1) and reactive groups or adsorptive groups to which the ligand can bond. When the ligand is bonded to these reactive or adsorptive groups to which the ligand can bind, the affinity particles described inclaim 3, i.e. the inorganic particles directly having the phosphorylcholine group represented by formula (1) and the ligand on their surface, are obtained. - The product form of the affinity particles described in
claim 2 is such that the user can bond any ligand to them depending on the substance to be captured (target substance). The product form of the affinity particles described inclaim 3 is such that the ligand is already bonded. The affinity particles described inclaim 1 are affinity particles having at least the phosphorylcholine group of formula (1) on the particle surface and their product form is such that the user can bind any ligand to them depending on the substance to be captured (target substance), regardless of the presence or absence of the ligand or reactive group or adsorptive group that can bind to the ligand. Affinity particles of any form are included as long as the phosphorylcholine group of formula (1) is present on the particle surface; for example, the forms described inclaim 2 andclaim 3 are included as well. - In the aforementioned reaction, leaving some carboxyl groups as reactive groups or adsorptive groups to which the ligand can bind can be made possible, for example, by adjusting the reaction quantity of the silane coupling agent having a carboxylic acid to which the phosphorylcholine group is introduced.
- It is also possible to react this carboxyl group with a compound having any functional group and use this functional group as the reactive group or adsorptive group to which the ligand can bind.
- “A Method of Binding the Ligand to the Particles Having Carboxyl Groups”
- When the ligand is a protein, inorganic particles having carboxyl groups on the surface are soaked in a solution of N-hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide to esterify the particle surface. Amino groups in the protein are reacted with these to bind the protein. It is also possible to react this hydroxyl group with a compound having any functional group and use this functional group as the reactive group or adsorptive group to which the ligand can bind.
- “A Method of Affinity Separation of a Target Substance”
- Using the affinity particles of the present invention obtained as described above, the affinity separation of a target substance of the present invention is carried out.
- The method of the present invention is a groundbreaking separation/purification method for a target substance in that high precision separation can be easily done by using inorganic particles.
- The method of the present invention contains the following 3 processes. The first process is omitted for the affinity particles to which the ligand is already bonded (claim 2) since this process has already been done for such particles.
- 1. The first process in which any ligand is chemically bonded to affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles or affinity particles that are characterized by having phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having reactive groups or adsorptive groups, that are capable of bonding with ligands having specific affinity with a certain target substance, covalently bonded or adsorbed onto the surface of inorganic particles.
- For example, 1 ml of a PBS solution of any ligand and affinity particles that are inorganic particles having the phosphorylcholine group represented by formula (1) covalently bonded onto their surface and reactive groups or adsorptive groups to which the ligand can bind covalently bonded or adsorbed on their surface are put into a 2 ml eppen tube, followed by gentle shaking at 4° C. for 30 minutes. This is centrifuged for 5 minutes at 5000 rpm and the supernatant is discarded. The sample is cleaned by adding 1 ml of a PBS solution to it, gently shaking it, centrifuging it for 5 minutes at 5000 rpm, and discarding the supernatant. This cleaning operation is repeated 3 times.
- 2. The second process in which the affinity particles prepared in the first process are dispersed in a liquid sample containing the target substance that is selectively captured by any ligand.
- For example, the affinity particles prepared in the first process are dispersed in a liquid sample containing the target substance that is selectively captured by any ligand, followed by gentle shaking for 30 minutes at 4° C. This is centrifuged for 5 minutes at 5000 rpm and the supernatant is discarded. The sample is cleaned by adding 1 ml of a PBS solution to it, gently shaking it, centrifuging it for 5 minutes at 5000 rpm, and discarding the supernatant. This cleaning operation is repeated 3 times.
- 3. The third process in which the captured target substance is recovered from the separated affinity particles.
- For example, for the purpose of recovering the captured target substance from the affinity particles, 1 ml of an elution buffer is added, followed by gentle shaking for 30 minutes at 4° C. to elute the target substance from the particles, and the supernatant is recovered. 1 ml of a PBS solution is added to it, followed by gentle shaking and centrifugation for 5 minutes at 5000 rpm, and the supernatant is recovered. This operation is repeated twice.
-
FIG. 1 is a schematic showing the differences between the target substance capture selectivity of the affinity particles of the present invention and conventional affinity particles. - Next, the present invention is described in detail by referring to Examples. The present invention is not limited to these Examples. The phosphorylcholine groups introduced onto the particle surface can be verified and quantified by the FT-IR and element analysis.
- “An aldehyde Chemical Compound Containing Phosphorylcholine Groups”
- 1-alpha-glycerophosphorylcholine (6.29 g) was dissolved in 210 ml of distilled water and cooled in an ice water bath. Sodium periodate (10.23 g) was added, followed by five hours of stirring. The reaction fluid was concentrated under reduced pressure and dried under reduced pressure; methanol was then used to extract the target substance. The structure is shown in the following chemical formula (6).
-
- “A Carboxylic Acid Chemical Compound Containing Phosphorylcholine Groups”
- 5 g of glycerophosphorylcholine, 17 g of sodium periodate, 81 mg of ruthenium trichloride n-hydrate, 70 g of ion-exchanged water and 30 g of acetonitrile were put into a 200 ml flask. After stirring for two hours at room temperature, filtering was carried out and the solvent was removed from the filtrate. Methanol was used to extract the target compound from the obtained solid product; methanol was then removed to obtain the target compound (7).
-
- “Compound of Formula (10)”
- 9.0 g of the compound of Synthesis example 1 was dissolved in 55 mL of dehydrated methanol, and the air inside the vessel was replaced by dry nitrogen. Next, 2.84 g of 3-aminopropyltrimethoxysilane was added to the methanol solution of
chemical compound 1. This mixed solution was stirred overnight at room temperature and cooled with ice; 1.39 g of sodium cyanohydroborate was then added and the temperature was returned back to room temperature, followed by 5 hours of stirring. During this time dry nitrogen was continued to be fed through the reaction vessel. After filtering the precipitation, a methanol solution of the target substance, i.e. the compound of the following formula (10), was obtained. - “Compound of Formula (11)”
- 5.0 g of the compound of Synthesis example 4 was dissolved in 300 mL of N,N′-dimethylformamide, and the air inside the vessel was replaced by dry nitrogen. 4.5 g of thionyl chloride was then added, followed by 15 minutes of stirring, after which 2.84 g of 3-aminopropyltrimethoxysilane and 9.5 g of triethylamine were added. This mixed solution was stirred at room temperature overnight and the precipitate was filtered to obtain an N,N′-dimethylformamide solution containing the target substance, i.e. the compound of the following formula (11).
- “Phosphorylcholine Particles (PC Particles (A)) that are Inorganic Particles Having Phosphorylcholine Groups Covalently Bonded onto Their Surface”
-
- 97.7 μl of a methanol solution containing 50 μmol of the compound of formula (10) prepared in Synthesis example 3 was sampled, to which 47.5 ml of methanol and 2.5 ml of distilled water were added, and then 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 80° C. overnight for coupling. After the refluxing, the particles were cleaned by means of centrifugation using methanol to obtain the PC particles of claim 1 (hereafter “PC particles (A)”).
FIG. 4 shows the P quantification measurements of the PC-treated particles (A) prepared in the aforementioned procedure using the surface modifier of Synthetic example 3. The PC introduction level thus determined was 3.1 μmol/g-particles, which confirmed the introduction of PC groups onto the particle surface. - “Phosphorylcholine Particles (PC Particles (B)) that are Inorganic Particles Having Phosphorylcholine Groups Covalently Bonded onto Their Surface”
- 278 μl of a dimethylformamide solution containing 50 μmol of the compound of formula (11) prepared in Synthesis example 4 was sampled, to which 50 ml of dimethylformamide was added, and then 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 160° C. overnight for coupling. After the refluxing, the particles were cleaned by means of centrifugation using methanol to obtain the PC particles of claim 1 (hereafter “PC particles (B)”).
FIG. 4 shows the P quantification measurements of the PC-treated particles (B) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4. The PC introduction level thus determined was 3.4 μmol/g-particles, which confirmed the introduction of PC groups onto the particle surface. - “Phosphorylcholine Particles (PC Particles (C)) that are Inorganic Particles Having Phosphorylcholine Groups Covalently Bonded onto Their Surface”
- 278 μl of a dimethylformamide solution containing 50 μmol of the compound of formula (11) prepared in Synthesis example 4 was sampled, to which 47.5 ml of dimethylformamide and 2.5 ml of distilled water were added, and then 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 160° C. overnight for coupling. After the refluxing, the particles were cleaned by means of centrifugation using methanol to obtain the PC particles of claim 1 (hereafter “PC particles (C)”).
FIG. 4 shows the P quantification measurements of the PC-treated particles (C) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4. The PC introduction level thus determined was 7.3 μmol/g-particles, which confirmed the introduction of PC groups onto the particle surface. - A 13C-CPMAS spectrum and a 13C-PSTMAS spectrum of the PC particles (A) of Reference example 1 are shown in
FIG. 5 . The PSTMAS spectrum selectively captures a spectrum of free moving molecular chains; this method is widely used for analysis of modifying chains on the particle surface. InFIG. 5 , a spectrum due to carbons in the phosphorylcholine group is observed at 54.2 ppm. - In the 31P-CPMAS spectrum of the PC particles (A) of Reference example 1 in
FIG. 6 , peaks are detected at almost the same chemical shifts as NaH2PO4, which is measured as a control; this verifies the presence of phosphate groups. The results shown above indicate that phosphorylcholine groups were introduced onto the carrier silica gel surface. - In
FIG. 5 , spectra due to propyl groups, the spacer, are observed near 9 ppm and 23 ppm, and spectra due to ethyls in phosphorylcholine are observed near 60 ppm and 69 ppm. What is described above indicates that the structures of formulas (10) and (11) are introduced onto the silica gel without being destroyed. -
FIG. 7 shows a FT-IR spectrum of the PC particles (C) of Reference example 3. Absorption specific to amide bonding is observed near 1650 cm−1. - “Evaluation of Non-Specific Protein Adsorption on Phosphorylcholine Particles”
- 25 mg each of untreated silica gel particles having no phosphorylcholine group introduced used in Reference example 1 (abbreviated as “untreated particles”) and the PC particles (A), (B), and (C) prepared in Reference examples 1, 2, and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing the distilled water by means of centrifugation, 1 ml of albumin (100 μg/ml) or lysozyme (100 μg/ml) was added, followed by a 1 hour reaction at room temperature and cleaning by means of centrifugation/purification (5,000 g) 5 times with PBS. 1 ml of SDS (1%) was then added, followed by a 1 hour reaction at room temperature and centrifugation (5,000 g); the supernatant was quantified with the Micro BCA method. The results are shown in
FIG. 8 . PC particles (A), which had been treated with phosphorylcholine groups, showed significantly suppressed adsorption of both albumin and lysozyme compared with the agarose particles. PC particles (B) and (C) showed even more suppressed adsorption of both albumin and lysozyme compared with untreated particles or PC particles (A). - “Affinity Particles (Af Particles (A)) that are Inorganic Particles Having Phosphorylcholine Groups and Amino Groups Covalently Bonded onto Their Surface”
- 87.9 μl of a methanol solution containing 45 μmol of the compound of formula (10) prepared in Synthesis example 3 and 50 μl of a methanol solution containing 5 μmol of 3-aminotrimethoxysilane were sampled, to which 47.5 ml of methanol and 2.5 ml of distilled water were added, and then 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 80° C. overnight for coupling. After the refluxing, the particles were cleaned by means of centrifugation using methanol to obtain the Af particles of claim 1 (hereafter “Af particles (A)”).
FIG. 4 shows the P quantification measurements of the Af particles (A) prepared in the aforementioned procedure using the surface modifier of Synthetic example 3. The PC introduction level thus determined was 2.7 μmol/g-particles, which confirmed the introduction of PC groups onto the particle surface. - “Affinity Particles (Af Particles (B)) that are Inorganic Particles Having Phosphorylcholine Groups and Amino Groups Covalently Bonded onto Their Surface”
- 250 μl of a dimethylformamide solution containing 45 μmol of the compound of formula (11) prepared in Synthesis example 4 and 50 μl of a dimethylformamide solution containing 5 μmol of 3-aminotrimethoxysilane were sampled, to which 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 160° C. overnight for coupling. After the refluxing, the particles were cleaned by means of centrifugation using methanol to obtain the affinity particles of claim 1 (hereafter “Af particles (B)”).
FIG. 4 shows the P quantification measurements of the Af particles (B) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4. The PC introduction level thus determined was 3.3 μmol/g-particles, which confirmed the introduction of PC groups onto the particle surface. - “Affinity Particles (Af Particles (C)) that are Inorganic Particles having Phosphorylcholine Groups and Amino Groups Covalently Bonded onto Their Surface”
- 250 μl of a methanol solution containing 45 μmol of the compound of formula (11) prepared in Synthesis example 4 and 50 μl of a dimethylformamide solution containing 5 μmol of 3-aminotrimethoxysilane were sampled, to which 47.5 ml of dimethylformamide and 2.5 ml of distilled water were added, and then 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 160° C. overnight for coupling. After the refluxing, the particles were cleaned by means of centrifugation using methanol to obtain the affinity particles of claim 1 (hereafter “Af particles (C)”).
FIG. 4 shows the P quantification measurements of the Af particles (C) prepared in the aforementioned procedure using the surface modifier of Synthetic example 4. The PC introduction level thus determined was 6.3 μmol/g-particles, which confirmed the introduction of PC groups onto the particle surface. - “Evaluation of the Selectivity of Affinity Particles,
Part 1” - Next, the affinity separation method shown in
claim 6 is described. 25 mg each of Af particles (A), (B), and (C) prepared in Examples 1, 2, and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing the distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium cyanotrihydroborate, for stabilizing the Schiff base, were added to these affinity particles and the reaction was carried out for 5 hours at room temperature, followed by a centrifugation/purification (5,000 g)operation 5 times using MQ water for cleaning. The affinity particles ofclaim 2 that have glutaraldehyde as reactive groups or adsorptive groups to which the ligand can bind were thus obtained. 1 ml of bovine albumin (1 mg/ml) or human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by 4 times of a centrifugation/purification (5,000 g) with PBS. This bovine albumin or human hemoglobin is the ligand. After this is the affinity separation method shown inclaim 7. 1 ml of ethanolamine hydrochloride (0.5 M, pH 7.1) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 hour at room temperature to deactivate the remaining glutaraldehyde, followed by 4 times of a centrifugation/purification (5,000 g) with PBS to obtain the affinity particles ofclaim 3. 1 ml of HRP-conjugated anti-bovine albumin antibody (10 μg/ml) or HRP-conjugated human hemoglobin antibody (10 μg/ml) was added and the reaction was carried out for 1 hour at room temperature, followed by 5 times of a centrifugation/purification (5,000 g) with PBS. An additional 1 ml of PBS was added, followed by stirring; 10 μl each was transferred onto a 96-well plate and a color development test was conducted using substrate TMBZ; the measurement was done at 450 nm. The results are shown inFIG. 9 ,FIG. 10 , andFIG. 11 . Af particles (A) exhibited selectivity for human hemoglobin-HRP conjugated anti-human hemoglobin antibody. Also, Af particles (B) and Af particles (C) exhibited selectivity for both bovine albumin-HRP conjugated anti-bovine albumin antibody and human hemoglobin-HRP conjugated anti-human hemoglobin antibody. - “Evaluation of the Selectivity of Affinity Particles,
Part 2” - Goat anti-serum for human hemoglobin was used to conduct a selectivity test. 25 mg each of Af particles (A) and (C) prepared in Examples 1 and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing the distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium cyanotrihydroborate, for stabilizing the Schiff base, were added to these affinity particles and the reaction was carried out for 5 hours at room temperature, followed by a centrifugation/purification (5,000 g)
operation 5 times using MQ water for cleaning. The affinity particles ofclaim 2 that have glutaraldehyde as reactive groups or adsorptive groups to which the ligand can bind were thus obtained. 1 ml human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by centrifugation/purification (5,000 g) 4 times with PBS. This human hemoglobin is the ligand. After this is the affinity separation method shown inclaim 7. 1 ml of ethanolamine hydrochloride (0.5 M, pH 7.1) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 hour at room. temperature to deactivate the remaining glutaraldehyde, followed by a centrifugation/purification (5,000 g) 4 times with PBS to obtain the affinity particles ofclaim 3. 1 ml of goat anti-serum, diluted 100 times, was then added, followed by a one hour reaction at room temperature. Centrifugation (5,000 g) was then conducted and the supernatant was sampled (supernatant fraction). Centrifugation/purification (5,000 g) was conducted 5 times using PBS. 1 ml of a Gly-HCl buffer (0.2M, pH 2.5) was then added and the reaction was carried out for one hour at room temperature to elute the anti-human hemoglobin antibody and centrifugation (5,000 g) was conducted to obtain the supernatant (elution fraction). This supernatant fraction and elution fraction were fed to SDS-PAGE, followed by silver staining; the results are shown inFIG. 12 . Both Af particles (A) and (C) exhibit a dark band of the heavy chain of the antibody but no other bands in the elution fraction, which indicates that the antibody was captured highly selectively. - “Evaluation of the Selectivity of Affinity Particles,
Part 3” - The goat anti-serum mixed with anti-human hemoglobin was used to conduct a selectivity test. 25 mg each of Af particles (A) and (C) prepared in Examples 1 and 3 were sampled, to each of which 1 ml of distilled water was added, followed by one minute of ultrasonic treatment. After removing distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium cyanotrihydroborate, for stabilizing the Schiff base, were added to these affinity particles and the reaction was carried out for 5 hours at room temperature, followed by a centrifugation/purification (5,000 g)
operation 5 times using MQ water for cleaning. The affinity particles ofclaim 2 that have glutaraldehyde as reactive groups or adsorptive groups to which the ligand can bind were thus obtained. 1 ml human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by a centrifugation/purification (5,000 g) 4 times with PBS. This human hemoglobin is the ligand. After this is the affinity separation method shown inclaim 7. 1 ml of ethanolamine hydrochloride (0.5 M, pH 7.1) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 hour at room temperature to deactivate the remaining glutaraldehyde, followed by a centrifugation/purification (5,000 g) 4 times with PBS to obtain the affinity particles ofclaim 3. 1 ml of goat anti-serum, diluted 100 times and mixed with 50 μg of anti-human hemoglobin, was then added, followed by a one hour reaction at room temperature. Centrifugation (5,000 g) was then conducted and the supernatant was sampled (supernatant fraction). Centrifugation/purification (5,000 g) was conducted 5 times using PBS. 1 ml of a Gly-HCl buffer (0.2M, pH 2.5) was then added and the reaction was carried out for one hour at room temperature to elute the anti-human hemoglobin antibody and centrifugation (5,000 g) was conducted to obtain the supernatant (elution fraction). This supernatant fraction and elution fraction were fed to SDS-PAGE, followed by silver staining; the results are shown inFIG. 13 . Both Af particles (A) and (C) exhibit a dark band of the heavy chain of the antibody but no other bands are faint, which indicates that the antibody was captured highly selectively.. The band darkness indicates that the antibody capture level is 10-20 μg. The antibody activity of the elution fractions were confirmed by means of sandwich ELISA; the activity was equivalent to 13 μg for Af particles (A) and 10.1 μg for Af particles (C). - “Affinity Particles (Amino Particles) that are Inorganic Particles Having Amino Groups Covalently Bonded onto Their Surface”
- 500 μl of a methanol solution containing 50 μmol of 3-aminopropyltrimethoxysilane was sampled, to which 47.5 ml of methanol and 2.5 ml of distilled water were added, and then 5 g of silica gel having an average particle size of 1.5 μm and a specific surface area of 6 m2/g was added. This particle dispersion was refluxed at 80° C. overnight for coupling. After refluxing and then cleaning by means of centrifugation using methanol, the amino particles were obtained. 1 ml of distilled water was added to 25 mg of these amino particles, followed by one minute of ultrasonic treatment. After removing distilled water by means of centrifugation, 1 ml of a glutaraldehyde solution (8%) and 10 mg of sodium cyanotrihydroborate, for stabilizing the Schiff base, were added to these affinity particles and the reaction was carried out for 5 hours at room temperature, followed by a centrifugation/purification (5,000 g)
operation 5 times using MQ water for cleaning. Glutaraldehyde is the reactive group or adsorptive group that can bind to the ligand. 1 ml of bovine albumin (1 mg/ml) or human hemoglobin (1 mg/ml) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 day at room temperature, followed by centrifugation/purification (5,000 g) 4 times with PBS. This bovine albumin or human hemoglobin is the ligand. 1 ml of ethanolamine hydrochloride (0.5 M, pH 7.1) and 10 mg of sodium trihydroborate were added and the reaction was carried out for 1 hour at room temperature to deactivate the remaining glutaraldehyde, followed by centrifugation/purification (5,000 g) 4 times with PBS to obtain the affinity particles ofclaim 3. 1 ml of HRP-conjugated anti-bovine albumin antibody (10 μg/ml) or HRP-conjugated human hemoglobin antibody (10 μg/ml) was added and the reaction was carried out for 1 hour at room temperature, followed by centrifugation/purification (5,000 g) 5 times with PBS. An additional 1 ml of PBS was added, followed by stirring; 10 μl each was transferred onto a 96-well plate and a color development test was conducted using substrate TMBZ; the measurement was done at 450 nm. The results are shown inFIG. 14 . There is a high level of non-specific adsorption of proteins and the selectivity is low. - The affinity particles of the present invention capture only the target protein that is desired to be separated and therefore they exhibit very high selectivity. They also exhibit superior dispersion properties and make separation from liquid samples very easy. Since a target substance can be separated easily with high accuracy using affinity particles made from inexpensive inorganic particles, the present invention is useful in bio-industries where a highly accurate separation and detection of the target substance is required.
Claims (13)
2. Affinity particles comprising phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having reactive groups or adsorptive groups, which are capable of bonding with ligands having specific affinity with a certain target substance, covalently bonded or adsorbed onto the surface of inorganic particles.
3. Affinity particles comprising phosphorylcholine groups represented by the following formula (1) covalently bonded onto the surface of inorganic particles and also by having ligands having specific affinity with a certain target substance covalently bonded or adsorbed onto the surface of inorganic particles.
4. The affinity particles of claim 1 , wherein said inorganic particles are selected from a group consisting of silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid, and having an average particle size of 20 nm to 500 μm and a specific gravity of 1.0 g/cm3 or higher.
5. The affinity particles of claim 1 , wherein said ligands are one, two, or more types of ligands chosen from a group consisting of various antibodies, antigens, enzymes, substrates, receptors, lectin, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
6. A method of affinity separation of a target substance by using inorganic particles comprising:
(1) a first process whereby arbitrary ligands are bonded to the affinity particles of claim 1 ,
(2) a second process whereby the affinity particles prepared in the first process are dispersed in a solution sample containing a target substance selectively captured by the arbitrary ligands, and
(3) a third process whereby the target substance captured is recovered from the affinity particles.
7. A method of affinity separation of a target substance by using inorganic particles comprising:
(1) a first process whereby the affinity particles of claim 3 are dispersed in a solution sample containing a target substance selectively captured by the arbitrary ligands, and
(2) a second process whereby the target substance captured is recovered from the affinity particles.
8. The affinity particles of claim 2 , wherein said inorganic particles are selected from a group consisting of silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid, and having an average particle size of 20 nm to 500 μm and a specific gravity of 1.0 g/cm3 or higher.
9. The affinity particles of claim 3 , wherein said inorganic particles are selected from a group consisting of silica, titanium oxide, zinc flower, alumina, iron oxide, talc, mica, sericite, and gold colloid, and having an average particle size of 20 nm to 500 μm and a specific gravity of 1.0 g/cm3 or higher.
10. The affinity particles of claim 2 , wherein said ligands are one, two, or more types of ligands chosen from a group consisting of various antibodies, antigens, enzymes, substrates, receptors, lectin, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
11. The affinity particles of claim 3 , wherein said ligands are one, two, or more types of ligands chosen from a group consisting of various antibodies, antigens, enzymes, substrates, receptors, lectin, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
12. The affinity particles of claim 4 , wherein said ligands are one, two, or more types of ligands chosen from a group consisting of various antibodies, antigens, enzymes, substrates, receptors, lectin, peptides, DNA, RNA, aptamers, protein A, protein G, avidin, biotin, chelating compounds, and various metal ions.
13. A method of affinity separation of a target substance by using inorganic particles comprising:
(1) a first process whereby arbitrary ligands are bonded to the affinity particles of claim 2 ,
(2) a second process whereby the affinity particles prepared in the first process are dispersed in a solution sample containing a target substance selectively captured by the arbitrary ligands, and
(3) a third process whereby the target substance captured is recovered from the affinity particles.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-153253 | 2004-05-24 | ||
JP2004153253 | 2004-05-24 | ||
JP2005138560A JP3922648B2 (en) | 2004-05-24 | 2005-05-11 | Affinity particles and affinity separation method |
JP2005-138560 | 2005-05-11 | ||
PCT/JP2005/009088 WO2005113135A1 (en) | 2004-05-24 | 2005-05-18 | Affinity particle and affinity separation method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/009088 A-371-Of-International WO2005113135A1 (en) | 2004-05-24 | 2005-05-18 | Affinity particle and affinity separation method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/495,936 Continuation US8551332B2 (en) | 2004-05-24 | 2009-07-01 | Affinity particle and affinity separation method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070181503A1 true US20070181503A1 (en) | 2007-08-09 |
Family
ID=35428284
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/580,000 Abandoned US20070181503A1 (en) | 2004-05-24 | 2005-05-18 | Affinity particle and affinity separation method |
US12/490,216 Abandoned US20090321357A1 (en) | 2004-05-24 | 2009-06-23 | Affinity Particle And Affinity Separation Method |
US12/495,936 Expired - Fee Related US8551332B2 (en) | 2004-05-24 | 2009-07-01 | Affinity particle and affinity separation method |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/490,216 Abandoned US20090321357A1 (en) | 2004-05-24 | 2009-06-23 | Affinity Particle And Affinity Separation Method |
US12/495,936 Expired - Fee Related US8551332B2 (en) | 2004-05-24 | 2009-07-01 | Affinity particle and affinity separation method |
Country Status (5)
Country | Link |
---|---|
US (3) | US20070181503A1 (en) |
EP (1) | EP1759761B1 (en) |
JP (1) | JP3922648B2 (en) |
KR (1) | KR101155655B1 (en) |
WO (1) | WO2005113135A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060060533A1 (en) * | 2002-11-25 | 2006-03-23 | Kazuyuki Miyazawa | Method of modifying surface of material |
US20070284297A1 (en) * | 2006-06-09 | 2007-12-13 | Marcello Gatti | Apparatus for the purification of organic molecules and relevant method of manufacture |
US20090149667A1 (en) * | 2007-12-05 | 2009-06-11 | Dai Nippon Printing Co., Ltd. | Method of producing substance immobilizing carrier |
US20110021756A1 (en) * | 2008-03-19 | 2011-01-27 | Katsuyuki Maeno | Method of manufacturing an affinity particle, affinity particle, and separation method |
US9347031B2 (en) | 2009-06-15 | 2016-05-24 | Shiseido Company, Ltd. | Container for forming a cell aggregate and a method for forming a cell aggregate |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006057384A1 (en) * | 2004-11-29 | 2006-06-01 | Shiseido Company, Ltd. | Phosphorylcholine group-containing compound and method for producing same |
JP5391265B2 (en) * | 2009-03-02 | 2014-01-15 | 株式会社 資生堂 | Biochip manufacturing method |
KR101283446B1 (en) * | 2010-11-10 | 2013-07-08 | 재단법인대구경북과학기술원 | Magnetic nanoparticles surface-modified with phosphocholine, preparing method of the same, and separating method of protein using the same |
JP5095855B2 (en) * | 2010-12-13 | 2012-12-12 | 株式会社 資生堂 | Method for forming cell aggregate |
ES2750337T3 (en) * | 2014-01-31 | 2020-03-25 | Siemens Healthcare Diagnostics Inc | Paramagnetic supports for use as test reagents |
CN110586022A (en) * | 2019-09-18 | 2019-12-20 | 沈阳航空航天大学 | Method for removing fatty acid from textile industrial wastewater by using acid-base modified porous boron nitride |
CN115073515B (en) * | 2022-06-29 | 2024-03-01 | 南京威尔药业科技有限公司 | Method for rapidly separating phospholipid components |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4298500A (en) * | 1980-05-05 | 1981-11-03 | Varian Associates, Inc. | Mixed phase chromatographic compositions |
US4415631A (en) * | 1980-06-27 | 1983-11-15 | Akzo | Porous inorganic support material coated with an organic stationary phase, for use in chromatography, and process for its preparation |
US4767670A (en) * | 1987-01-21 | 1988-08-30 | E. I. Du Pont De Nemours And Company | Chromatographic supports for separation of oligonucleotides |
US5045190A (en) * | 1988-11-08 | 1991-09-03 | Carbonell Ruben G | Chromatography apparatus |
US5137627A (en) * | 1989-03-02 | 1992-08-11 | Supelco, Inc. | Deactivated supports for liquid chromatographic separation of silanophiles |
US5141806A (en) * | 1989-10-31 | 1992-08-25 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microporous structure with layered interstitial surface treatment, and method and apparatus for preparation thereof |
US5277813A (en) * | 1988-06-17 | 1994-01-11 | S.A.C. Corporation | Shielded stationary phases |
US5374755A (en) * | 1992-07-17 | 1994-12-20 | Millipore Corporation | Liquid chromatography stationary phases with reduced silanol interactions |
US5431807A (en) * | 1992-10-21 | 1995-07-11 | Cornell Research Foundation, Inc. | Multimodal chromatographic separation media and process for using same |
US5438000A (en) * | 1992-11-12 | 1995-08-01 | Nippon Paint Co., Ltd. | Serum separation sealant |
US20020005380A1 (en) * | 2000-05-31 | 2002-01-17 | Takaya Sato | Bioreactor carrier, process for producing the carrier and method for using the same |
US6884345B1 (en) * | 1998-11-09 | 2005-04-26 | Knut Irgum | Chromatography method and a column material useful in said method |
US20060060533A1 (en) * | 2002-11-25 | 2006-03-23 | Kazuyuki Miyazawa | Method of modifying surface of material |
US7125488B2 (en) * | 2004-02-12 | 2006-10-24 | Varian, Inc. | Polar-modified bonded phase materials for chromatographic separations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59169532A (en) * | 1983-03-17 | 1984-09-25 | Asahi Chem Ind Co Ltd | Adsorbing material of c-reactive protein |
JPH0833380B2 (en) * | 1986-12-03 | 1996-03-29 | 東ソー株式会社 | Filler for liquid chromatography |
GB9301702D0 (en) * | 1993-01-28 | 1993-03-17 | Biocompatibles Ltd | New materials |
JPH0826076A (en) * | 1994-07-19 | 1996-01-30 | Asmo Co Ltd | Raindroplet removing device for vehicle |
JP3884510B2 (en) * | 1996-10-14 | 2007-02-21 | 日本油脂株式会社 | Method for stabilizing immobilized immunologically active substances during storage |
WO1998058257A1 (en) | 1997-06-18 | 1998-12-23 | Innova Gesellschaft Zur Entwicklung Und Vermarktung Innovativer Produkte Mbh | Magnetic particles with biologically active receptors |
US6258264B1 (en) * | 1998-04-10 | 2001-07-10 | Transgenomic, Inc. | Non-polar media for polynucleotide separations |
JP4680361B2 (en) * | 2000-09-22 | 2011-05-11 | 一彦 石原 | Separation / collection method |
JP4434517B2 (en) * | 2001-06-11 | 2010-03-17 | Junken Medical株式会社 | Adsorbent |
-
2005
- 2005-05-11 JP JP2005138560A patent/JP3922648B2/en not_active Expired - Fee Related
- 2005-05-18 KR KR1020067015857A patent/KR101155655B1/en not_active IP Right Cessation
- 2005-05-18 EP EP05741368A patent/EP1759761B1/en not_active Not-in-force
- 2005-05-18 US US11/580,000 patent/US20070181503A1/en not_active Abandoned
- 2005-05-18 WO PCT/JP2005/009088 patent/WO2005113135A1/en not_active Application Discontinuation
-
2009
- 2009-06-23 US US12/490,216 patent/US20090321357A1/en not_active Abandoned
- 2009-07-01 US US12/495,936 patent/US8551332B2/en not_active Expired - Fee Related
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4298500A (en) * | 1980-05-05 | 1981-11-03 | Varian Associates, Inc. | Mixed phase chromatographic compositions |
US4415631A (en) * | 1980-06-27 | 1983-11-15 | Akzo | Porous inorganic support material coated with an organic stationary phase, for use in chromatography, and process for its preparation |
US4767670A (en) * | 1987-01-21 | 1988-08-30 | E. I. Du Pont De Nemours And Company | Chromatographic supports for separation of oligonucleotides |
US5277813A (en) * | 1988-06-17 | 1994-01-11 | S.A.C. Corporation | Shielded stationary phases |
US5045190A (en) * | 1988-11-08 | 1991-09-03 | Carbonell Ruben G | Chromatography apparatus |
US5137627A (en) * | 1989-03-02 | 1992-08-11 | Supelco, Inc. | Deactivated supports for liquid chromatographic separation of silanophiles |
US5141806A (en) * | 1989-10-31 | 1992-08-25 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microporous structure with layered interstitial surface treatment, and method and apparatus for preparation thereof |
US5374755A (en) * | 1992-07-17 | 1994-12-20 | Millipore Corporation | Liquid chromatography stationary phases with reduced silanol interactions |
US5431807A (en) * | 1992-10-21 | 1995-07-11 | Cornell Research Foundation, Inc. | Multimodal chromatographic separation media and process for using same |
US5438000A (en) * | 1992-11-12 | 1995-08-01 | Nippon Paint Co., Ltd. | Serum separation sealant |
US6884345B1 (en) * | 1998-11-09 | 2005-04-26 | Knut Irgum | Chromatography method and a column material useful in said method |
US20020005380A1 (en) * | 2000-05-31 | 2002-01-17 | Takaya Sato | Bioreactor carrier, process for producing the carrier and method for using the same |
US20060060533A1 (en) * | 2002-11-25 | 2006-03-23 | Kazuyuki Miyazawa | Method of modifying surface of material |
US7125488B2 (en) * | 2004-02-12 | 2006-10-24 | Varian, Inc. | Polar-modified bonded phase materials for chromatographic separations |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060060533A1 (en) * | 2002-11-25 | 2006-03-23 | Kazuyuki Miyazawa | Method of modifying surface of material |
US7560023B2 (en) * | 2002-11-25 | 2009-07-14 | Shiseido Company, Ltd. | Method of modifying surface of material |
US20070284297A1 (en) * | 2006-06-09 | 2007-12-13 | Marcello Gatti | Apparatus for the purification of organic molecules and relevant method of manufacture |
US20090149667A1 (en) * | 2007-12-05 | 2009-06-11 | Dai Nippon Printing Co., Ltd. | Method of producing substance immobilizing carrier |
US8293933B2 (en) | 2007-12-05 | 2012-10-23 | Dai Nippon Printing Co., Ltd. | Method of producing substance immobilizing carrier |
US20110021756A1 (en) * | 2008-03-19 | 2011-01-27 | Katsuyuki Maeno | Method of manufacturing an affinity particle, affinity particle, and separation method |
US9347031B2 (en) | 2009-06-15 | 2016-05-24 | Shiseido Company, Ltd. | Container for forming a cell aggregate and a method for forming a cell aggregate |
Also Published As
Publication number | Publication date |
---|---|
EP1759761A4 (en) | 2008-11-05 |
EP1759761A1 (en) | 2007-03-07 |
EP1759761B1 (en) | 2011-07-27 |
KR20070053650A (en) | 2007-05-25 |
US8551332B2 (en) | 2013-10-08 |
US20090321357A1 (en) | 2009-12-31 |
US20100137133A1 (en) | 2010-06-03 |
KR101155655B1 (en) | 2012-06-13 |
JP3922648B2 (en) | 2007-05-30 |
WO2005113135A1 (en) | 2005-12-01 |
JP2006007204A (en) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8551332B2 (en) | Affinity particle and affinity separation method | |
US20090321358A1 (en) | Affinity Particle And Method Of Affinity Separation | |
US10859477B2 (en) | Bioseparation compositions and methods for making and using same | |
WO2009119355A1 (en) | Method for immobilization, physiologically active substance-immobilized carrier, carrier for immobilization, carrier, and process for producing carrier | |
JP5421900B2 (en) | Method for producing affinity particles | |
CN114650882A (en) | Materials and methods for mixed mode anion exchange reverse phase liquid chromatography | |
CN103285840B (en) | Embedded triazine ring amide silica gel stationary phase for liquid chromatograph and preparation method thereof | |
JP2007511523A (en) | N-sulfonyldicarboximide-containing tethering compound | |
CN116789771B (en) | Antibacterial polypeptide modified protein derivative and preparation method and application thereof | |
JP5388462B2 (en) | Carrier and production method thereof | |
US6562961B1 (en) | Aminoalkyl trialkyl silyl cellulose and a method for coating surfaces | |
JP5391265B2 (en) | Biochip manufacturing method | |
JP2015520657A (en) | Dope material for reverse phase chromatography | |
KR101176905B1 (en) | Affinity particle and method of affinity separation | |
CN1956779B (en) | Affinity particle and affinity separation method | |
US7175767B2 (en) | Preparation of a metal chelating separation medium | |
CN114041052A (en) | Coatings with immobilized affinity ligands and enzymes and their use in liquid chromatography assays | |
UA10467U (en) | Method for preparation of magnetic nanodimensional sorbent for immunological and biochemical objects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SHISEIDO COMPANY, LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAENO, KATSUYUKI;MIYAZAWA, KAZUYUKI;ISHIKUBO, AKIRA;AND OTHERS;REEL/FRAME:018596/0988;SIGNING DATES FROM 20061016 TO 20061023 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |